BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA. 2011;108 Suppl 1:4523-4530. [PMID: 20837534 DOI: 10.1073/pnas.1006734107] [Cited by in Crossref: 425] [Cited by in F6Publishing: 371] [Article Influence: 38.6] [Reference Citation Analysis]
Number Citing Articles
1 Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B, Huffnagle GB, Z Li J, Young VB. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 2014;5:3114. [PMID: 24445449 DOI: 10.1038/ncomms4114] [Cited by in Crossref: 520] [Cited by in F6Publishing: 427] [Article Influence: 86.7] [Reference Citation Analysis]
2 Sarafian MH, Lewis MR, Pechlivanis A, Ralphs S, Mcphail MJW, Patel VC, Dumas M, Holmes E, Nicholson JK. Bile Acid Profiling and Quantification in Biofluids Using Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry. Anal Chem 2015;87:9662-70. [DOI: 10.1021/acs.analchem.5b01556] [Cited by in Crossref: 114] [Cited by in F6Publishing: 90] [Article Influence: 19.0] [Reference Citation Analysis]
3 Kuver R. The expanding universe of bile acid physiology: delving into the mysteries of dark (green) matter. J Surg Res 2013;182:207-9. [PMID: 22502870 DOI: 10.1016/j.jss.2012.03.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Zhang S, Jin Y, Zeng Z, Liu Z, Fu Z. Subchronic Exposure of Mice to Cadmium Perturbs Their Hepatic Energy Metabolism and Gut Microbiome. Chem Res Toxicol 2015;28:2000-9. [DOI: 10.1021/acs.chemrestox.5b00237] [Cited by in Crossref: 111] [Cited by in F6Publishing: 91] [Article Influence: 18.5] [Reference Citation Analysis]
5 Yang H, Yang T, Heng C, Zhou Y, Jiang Z, Qian X, Du L, Mao S, Yin X, Lu Q. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice. Phytother Res 2019;33:3140-52. [PMID: 31452288 DOI: 10.1002/ptr.6486] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 14.5] [Reference Citation Analysis]
6 Want EJ, Masson P, Michopoulos F, Wilson ID, Theodoridis G, Plumb RS, Shockcor J, Loftus N, Holmes E, Nicholson JK. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc 2013;8:17-32. [PMID: 23222455 DOI: 10.1038/nprot.2012.135] [Cited by in Crossref: 324] [Cited by in F6Publishing: 245] [Article Influence: 36.0] [Reference Citation Analysis]
7 Aron-Wisnewsky J, Doré J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9:590-598. [PMID: 22926153 DOI: 10.1038/nrgastro.2012.161] [Cited by in Crossref: 145] [Cited by in F6Publishing: 112] [Article Influence: 16.1] [Reference Citation Analysis]
8 Org E, Mehrabian M, Lusis AJ. Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota. Atherosclerosis. 2015;241:387-399. [PMID: 26071662 DOI: 10.1016/j.atherosclerosis.2015.05.035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
9 Perino A, Schoonjans K. TGR5 and Immunometabolism: Insights from Physiology and Pharmacology. Trends Pharmacol Sci. 2015;36:847-857. [PMID: 26541439 DOI: 10.1016/j.tips.2015.08.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 12.0] [Reference Citation Analysis]
10 Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016;22:1079-89. [PMID: 27711063 DOI: 10.1038/nm.4185] [Reference Citation Analysis]
11 Fianchi F, Liguori A, Gasbarrini A, Grieco A, Miele L. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. Int J Mol Sci 2021;22:6485. [PMID: 34204274 DOI: 10.3390/ijms22126485] [Reference Citation Analysis]
12 Guo J, Han X, Tan H, Huang W, You Y, Zhan J. Blueberry Extract Improves Obesity through Regulation of the Gut Microbiota and Bile Acids via Pathways Involving FXR and TGR5. iScience 2019;19:676-90. [PMID: 31472342 DOI: 10.1016/j.isci.2019.08.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
13 Zhong W, Zhou Z. Alterations of the gut microbiome and metabolome in alcoholic liver disease. World J Gastrointest Pathophysiol 2014;5:514-22. [PMID: 25400995 DOI: 10.4291/wjgp.v5.i4.514] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
14 Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol. 2012;3:448. [PMID: 23226130 DOI: 10.3389/fphys.2012.00448] [Cited by in Crossref: 234] [Cited by in F6Publishing: 201] [Article Influence: 26.0] [Reference Citation Analysis]
15 Neuschwander-tetri BA. Farnesoid X Receptor Agonists: What They Are and How They Might Be Used in Treating Liver Disease. Curr Gastroenterol Rep 2012;14:55-62. [DOI: 10.1007/s11894-011-0232-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang C, Zhu C, Shao L, Ye J, Shen Y, Ren Y. Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. Mediators Inflamm. 2019;2019:7659509. [PMID: 31341422 DOI: 10.1155/2019/7659509] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
17 Gao B, Bian X, Mahbub R, Lu K. Sex-Specific Effects of Organophosphate Diazinon on the Gut Microbiome and Its Metabolic Functions. Environ Health Perspect 2017;125:198-206. [PMID: 27203275 DOI: 10.1289/EHP202] [Cited by in Crossref: 67] [Cited by in F6Publishing: 31] [Article Influence: 13.4] [Reference Citation Analysis]
18 Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity. Curr Opin Microbiol. 2017;35:8-15. [PMID: 27883933 DOI: 10.1016/j.mib.2016.10.003] [Cited by in Crossref: 157] [Cited by in F6Publishing: 128] [Article Influence: 31.4] [Reference Citation Analysis]
19 Gérard P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 2013;3:14-24. [PMID: 25437605 DOI: 10.3390/pathogens3010014] [Cited by in Crossref: 258] [Cited by in F6Publishing: 205] [Article Influence: 32.3] [Reference Citation Analysis]
20 Wei M, Shao Y, Liu QR, Wu QZ, Zhang X, Zhong MW, Liu SZ, Zhang GY, Hu SY. Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries. Am J Physiol Gastrointest Liver Physiol 2018;314:G537-46. [PMID: 29351394 DOI: 10.1152/ajpgi.00311.2017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Choi MS, Yu JS, Yoo HH, Kim D. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs. Pharmacological Research 2018;130:164-71. [DOI: 10.1016/j.phrs.2018.01.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
22 Cummings BP, Bettaieb A, Graham JL, Kim J, Ma F, Shibata N, Stanhope KL, Giulivi C, Hansen F, Jelsing J. Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats. Dis Model Mech. 2013;6:443-456. [PMID: 23264565 DOI: 10.1242/dmm.010421] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
23 Fabbiano S, Suárez-Zamorano N, Trajkovski M. Host-Microbiota Mutualism in Metabolic Diseases. Front Endocrinol (Lausanne) 2017;8:267. [PMID: 29056925 DOI: 10.3389/fendo.2017.00267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
24 Badiee M, Tochtrop GP. Bile Acid Recognition by Mouse Ileal Bile Acid Binding Protein. ACS Chem Biol 2017;12:3049-56. [PMID: 29058872 DOI: 10.1021/acschembio.7b00865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
25 Yan N, Yan T, Xia Y, Hao H, Wang G, Gonzalez FJ. The pathophysiological function of non-gastrointestinal farnesoid X receptor. Pharmacol Ther 2021;226:107867. [PMID: 33895191 DOI: 10.1016/j.pharmthera.2021.107867] [Reference Citation Analysis]
26 Visconti A, Le Roy CI, Rosa F, Rossi N, Martin TC, Mohney RP, Li W, de Rinaldis E, Bell JT, Venter JC, Nelson KE, Spector TD, Falchi M. Interplay between the human gut microbiome and host metabolism. Nat Commun 2019;10:4505. [PMID: 31582752 DOI: 10.1038/s41467-019-12476-z] [Cited by in Crossref: 124] [Cited by in F6Publishing: 97] [Article Influence: 62.0] [Reference Citation Analysis]
27 Guerrant RL, DeBoer MD, Moore SR, Scharf RJ, Lima AA. The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease. Nat Rev Gastroenterol Hepatol 2013;10:220-9. [PMID: 23229327 DOI: 10.1038/nrgastro.2012.239] [Cited by in Crossref: 295] [Cited by in F6Publishing: 213] [Article Influence: 32.8] [Reference Citation Analysis]
28 Swann JR, Claus SP. Nutrimetabonomics: nutritional applications of metabolic profiling. Sci Prog 2014;97:41-7. [PMID: 24800468 DOI: 10.3184/003685014X13898807933527] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
29 Behr C, Ramírez-Hincapié S, Cameron HJ, Strauss V, Walk T, Herold M, Beekmann K, Rietjens IMCM, van Ravenzwaay B. Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces. Toxicol Lett 2018;296:139-51. [PMID: 30102961 DOI: 10.1016/j.toxlet.2018.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
30 Khan TJ, Hasan MN, Azhar EI, Yasir M. Association of gut dysbiosis with intestinal metabolites in response to antibiotic treatment. Human Microbiome Journal 2019;11:100054. [DOI: 10.1016/j.humic.2018.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Mazuy C, Helleboid A, Staels B, Lefebvre P. Nuclear bile acid signaling through the farnesoid X receptor. Cell Mol Life Sci. 2015;72:1631-1650. [PMID: 25511198 DOI: 10.1007/s00018-014-1805-y] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 10.0] [Reference Citation Analysis]
32 Zhai Q, Liu Y, Wang C, Qu D, Zhao J, Zhang H, Tian F, Chen W. Lactobacillus plantarum CCFM8661 modulates bile acid enterohepatic circulation and increases lead excretion in mice. Food Funct 2019;10:1455-64. [DOI: 10.1039/c8fo02554a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
33 Haring E, Uhl FM, Andrieux G, Proietti M, Bulashevska A, Sauer B, Braun LM, de Vega Gomez E, Esser PR, Martin SF, Pfeifer D, Follo M, Schmitt-Graeff A, Buescher J, Duyster J, Grimbacher B, Boerries M, Pearce EL, Zeiser R, Apostolova P. Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect. Haematologica 2021;106:2131-46. [PMID: 32675222 DOI: 10.3324/haematol.2019.242990] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
34 Jiménez E, Sánchez B, Farina A, Margolles A, Rodríguez JM. Characterization of the bile and gall bladder microbiota of healthy pigs. Microbiologyopen 2014;3:937-49. [PMID: 25336405 DOI: 10.1002/mbo3.218] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
35 Bahr SM, Weidemann BJ, Castro AN, Walsh JW, deLeon O, Burnett CM, Pearson NA, Murry DJ, Grobe JL, Kirby JR. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2015;2:1725-34. [PMID: 26870798 DOI: 10.1016/j.ebiom.2015.10.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 14.0] [Reference Citation Analysis]
36 de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657-669. [PMID: 23602448 DOI: 10.1016/j.cmet.2013.03.013] [Cited by in Crossref: 478] [Cited by in F6Publishing: 411] [Article Influence: 59.8] [Reference Citation Analysis]
37 Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging. Physiol Rev 2021;101:683-731. [PMID: 32790577 DOI: 10.1152/physrev.00049.2019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
38 Shah RM, McKenzie EJ, Rosin MT, Jadhav SR, Gondalia SV, Rosendale D, Beale DJ. An Integrated Multi-Disciplinary Perspectivefor Addressing Challenges of the Human Gut Microbiome. Metabolites 2020;10:E94. [PMID: 32155792 DOI: 10.3390/metabo10030094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
39 Miraglia F, Colla E. Microbiome, Parkinson's Disease and Molecular Mimicry. Cells 2019;8:E222. [PMID: 30866550 DOI: 10.3390/cells8030222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
40 McFall-Ngai M, Hadfield MG, Bosch TC, Carey HV, Domazet-Lošo T, Douglas AE, Dubilier N, Eberl G, Fukami T, Gilbert SF, Hentschel U, King N, Kjelleberg S, Knoll AH, Kremer N, Mazmanian SK, Metcalf JL, Nealson K, Pierce NE, Rawls JF, Reid A, Ruby EG, Rumpho M, Sanders JG, Tautz D, Wernegreen JJ. Animals in a bacterial world, a new imperative for the life sciences. Proc Natl Acad Sci U S A 2013;110:3229-36. [PMID: 23391737 DOI: 10.1073/pnas.1218525110] [Cited by in Crossref: 1410] [Cited by in F6Publishing: 972] [Article Influence: 176.3] [Reference Citation Analysis]
41 Newman TM, Vitolins MZ, Cook KL. From the Table to the Tumor: The Role of Mediterranean and Western Dietary Patterns in Shifting Microbial-Mediated Signaling to Impact Breast Cancer Risk. Nutrients 2019;11:E2565. [PMID: 31652909 DOI: 10.3390/nu11112565] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
42 Palau-Rodriguez M, Tulipani S, Isabel Queipo-Ortuño M, Urpi-Sarda M, Tinahones FJ, Andres-Lacueva C. Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes. Front Microbiol 2015;6:1151. [PMID: 26579078 DOI: 10.3389/fmicb.2015.01151] [Cited by in F6Publishing: 54] [Reference Citation Analysis]
43 Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214. [PMID: 24009397 DOI: 10.1126/science.1241214] [Cited by in Crossref: 2021] [Cited by in F6Publishing: 1701] [Article Influence: 252.6] [Reference Citation Analysis]
44 Ovadia C, Perdones-Montero A, Spagou K, Smith A, Sarafian MH, Gomez-Romero M, Bellafante E, Clarke LCD, Sadiq F, Nikolova V, Mitchell A, Dixon PH, Santa-Pinter N, Wahlström A, Abu-Hayyeh S, Walters JRF, Marschall HU, Holmes E, Marchesi JR, Williamson C. Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis. Hepatology 2019;70:276-93. [PMID: 30983011 DOI: 10.1002/hep.30661] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
45 Xie G, Wang Y, Wang X, Zhao A, Chen T, Ni Y, Wong L, Zhang H, Zhang J, Liu C, Liu P, Jia W. Profiling of serum bile acids in a healthy Chinese population using UPLC-MS/MS. J Proteome Res 2015;14:850-9. [PMID: 25581415 DOI: 10.1021/pr500920q] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 11.7] [Reference Citation Analysis]
46 Péan N, Doignon I, Tordjmann T. Gut microbiota and bile acids: an old story revisited (again). Clin Res Hepatol Gastroenterol 2014;38:129-31. [PMID: 23916556 DOI: 10.1016/j.clinre.2013.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
47 Xie G, Wang X, Huang F, Zhao A, Chen W, Yan J, Zhang Y, Lei S, Ge K, Zheng X, Liu J, Su M, Liu P, Jia W. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. Int J Cancer 2016;139:1764-75. [PMID: 27273788 DOI: 10.1002/ijc.30219] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 17.4] [Reference Citation Analysis]
48 Anahtar MN, Gootenberg DB, Mitchell CM, Kwon DS. Cervicovaginal Microbiota and Reproductive Health: The Virtue of Simplicity. Cell Host Microbe 2018;23:159-68. [PMID: 29447695 DOI: 10.1016/j.chom.2018.01.013] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 23.3] [Reference Citation Analysis]
49 Ding Z, Hani A, Li W, Gao L, Ke W, Guo X. Influence of a cholesterol-lowering strain Lactobacillus plantarum LP3 isolated from traditional fermented yak milk on gut bacterial microbiota and metabolome of rats fed with a high-fat diet. Food Funct 2020;11:8342-53. [PMID: 32930686 DOI: 10.1039/d0fo01939a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Kaur H, Seeger D, Golovko S, Golovko M, Combs CK. Liver Bile Acid Changes in Mouse Models of Alzheimer's Disease. Int J Mol Sci 2021;22:7451. [PMID: 34299071 DOI: 10.3390/ijms22147451] [Reference Citation Analysis]
51 Blesl A, Jüngst C, Lammert F, Fauler G, Rainer F, Leber B, Feldbacher N, Stromberger S, Wildburger R, Spindelböck W, Fickert P, Horvath A, Stadlbauer V. Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study. Nutrients 2020;12:E2728. [PMID: 32906634 DOI: 10.3390/nu12092728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Xie G, Jia W. Using metabolomics to analyse the role of gut microbiota in nutrition and disease. Metabolomics as a Tool in Nutrition Research. Elsevier; 2015. pp. 115-36. [DOI: 10.1016/b978-1-78242-084-2.00006-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Schnabl B. Linking intestinal homeostasis and liver disease. Curr Opin Gastroenterol 2013;29:264-70. [PMID: 23493073 DOI: 10.1097/MOG.0b013e32835ff948] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
54 Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411-428. [PMID: 31028350 DOI: 10.1038/s41575-019-0145-7] [Cited by in Crossref: 268] [Cited by in F6Publishing: 233] [Article Influence: 134.0] [Reference Citation Analysis]
55 Sun J, Chang EB. Exploring gut microbes in human health and disease: Pushing the envelope. Genes Dis. 2014;1:132-139. [PMID: 25642449 DOI: 10.1016/j.gendis.2014.08.001] [Cited by in Crossref: 98] [Cited by in F6Publishing: 69] [Article Influence: 14.0] [Reference Citation Analysis]
56 Druart C, Alligier M, Salazar N, Neyrinck AM, Delzenne NM. Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. Adv Nutr 2014;5:624S-33S. [PMID: 25225347 DOI: 10.3945/an.114.005835] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 8.4] [Reference Citation Analysis]
57 Holzer P, Farzi A, Hassan AM, Zenz G, Jačan A, Reichmann F. Visceral Inflammation and Immune Activation Stress the Brain. Front Immunol 2017;8:1613. [PMID: 29213271 DOI: 10.3389/fimmu.2017.01613] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
58 Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, Sidaway JE, Martin G, Gloor GB, Swann JR. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail. 2014;7:491-499. [PMID: 24625365 DOI: 10.1161/circheartfailure.113.000978] [Cited by in Crossref: 107] [Cited by in F6Publishing: 67] [Article Influence: 15.3] [Reference Citation Analysis]
59 Connor KL, Chehoud C, Altrichter A, Chan L, DeSantis TZ, Lye SJ. Maternal metabolic, immune, and microbial systems in late pregnancy vary with malnutrition in mice. Biol Reprod 2018;98:579-92. [PMID: 29324977 DOI: 10.1093/biolre/ioy002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
60 Chi L, Bian X, Gao B, Tu P, Lai Y, Ru H, Lu K. Effects of the Artificial Sweetener Neotame on the Gut Microbiome and Fecal Metabolites in Mice.Molecules. 2018;23. [PMID: 29425148 DOI: 10.3390/molecules23020367] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
61 Greuter T, Malhi H, Gores GJ, Shah VH. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2017;2:95354. [PMID: 28878132 DOI: 10.1172/jci.insight.95354] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
62 He X, Marco ML, Slupsky CM. Emerging aspects of food and nutrition on gut microbiota. J Agric Food Chem 2013;61:9559-74. [PMID: 24028159 DOI: 10.1021/jf4029046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
63 Fukuda S, Ohno H. Gut microbiome and metabolic diseases. Semin Immunopathol. 2014;36:103-114. [PMID: 24196453 DOI: 10.1007/s00281-013-0399-z] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 10.9] [Reference Citation Analysis]
64 Caspani G, Swann J. Small talk: microbial metabolites involved in the signaling from microbiota to brain. Curr Opin Pharmacol 2019;48:99-106. [PMID: 31525562 DOI: 10.1016/j.coph.2019.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
65 Bourgin M, Labarthe S, Kriaa A, Lhomme M, Gérard P, Lesnik P, Laroche B, Maguin E, Rhimi M. Exploring the Bacterial Impact on Cholesterol Cycle: A Numerical Study. Front Microbiol 2020;11:1121. [PMID: 32587579 DOI: 10.3389/fmicb.2020.01121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
66 Mansour AT, El-Feky MMM, El-Beltagi HS, Sallam AE. Synergism of Dietary Co-Supplementation with Lutein and Bile Salts Improved the Growth Performance, Carotenoid Content, Antioxidant Capacity, Lipid Metabolism, and Lipase Activity of the Marbled Spinefoot Rabbitfish, Siganus rivulatus. Animals (Basel) 2020;10:E1643. [PMID: 32932710 DOI: 10.3390/ani10091643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Vlasova AN, Takanashi S, Miyazaki A, Rajashekara G, Saif LJ. How the gut microbiome regulates host immune responses to viral vaccines. Curr Opin Virol 2019;37:16-25. [PMID: 31163292 DOI: 10.1016/j.coviro.2019.05.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
68 Lee-Sarwar KA, Lasky-Su J, Kelly RS, Litonjua AA, Weiss ST. Gut Microbial-Derived Metabolomics of Asthma. Metabolites 2020;10:E97. [PMID: 32155960 DOI: 10.3390/metabo10030097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
69 Singh J, Metrani R, Shivanagoudra SR, Jayaprakasha GK, Patil BS. Review on Bile Acids: Effects of the Gut Microbiome, Interactions with Dietary Fiber, and Alterations in the Bioaccessibility of Bioactive Compounds. J Agric Food Chem 2019;67:9124-38. [PMID: 30969768 DOI: 10.1021/acs.jafc.8b07306] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 18.5] [Reference Citation Analysis]
70 Jia ET, Liu ZY, Pan M, Lu JF, Ge QY. Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases. J Zhejiang Univ Sci B 2019;20:781-92. [PMID: 31489798 DOI: 10.1631/jzus.B1900073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
71 Caparrós-Martín JA, Lareu RR, Ramsay JP, Peplies J, Reen FJ, Headlam HA, Ward NC, Croft KD, Newsholme P, Hughes JD, O'Gara F. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome 2017;5:95. [PMID: 28793934 DOI: 10.1186/s40168-017-0312-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 17.5] [Reference Citation Analysis]
72 Schneider KM, Albers S, Trautwein C. Role of bile acids in the gut-liver axis. Journal of Hepatology 2018;68:1083-5. [DOI: 10.1016/j.jhep.2017.11.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
73 Pokusaeva DP, Anikhovskaya IA, Korobkova LA, Enukidze GG, Yakovlev MY. Prognostic Importance of Systemic Endotoxinemia Indicators in Atherogenesis. Hum Physiol 2019;45:543-51. [DOI: 10.1134/s036211971905013x] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
74 Hahn L, Helmrich N, Herebian D, Mayatepek E, Drebber U, Domann E, Olejniczak S, Weigel M, Hain T, Rath T, Wirtz S, Mollenkopf HJ, Schmidt N, Ewers C, Baier A, Churin Y, Windhorst A, Weiskirchen R, Steinhoff U, Roeb E, Roderfeld M. IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice. Cells 2020;9:E1949. [PMID: 32846954 DOI: 10.3390/cells9091949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Wang X, Cui DN, Dai XM, Wang J, Zhang W, Zhang ZJ, Xu FG. HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis. Front Pharmacol 2017;8:156. [PMID: 28424615 DOI: 10.3389/fphar.2017.00156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
76 Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676-684. [PMID: 23778795 DOI: 10.1038/ni.2640] [Cited by in Crossref: 500] [Cited by in F6Publishing: 407] [Article Influence: 62.5] [Reference Citation Analysis]
77 Zheng Y, Yu B, Alexander D, Couper DJ, Boerwinkle E. Medium-term variability of the human serum metabolome in the Atherosclerosis Risk in Communities (ARIC) study. OMICS 2014;18:364-73. [PMID: 24910946 DOI: 10.1089/omi.2014.0019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
78 Kanmani P, Suganya K, Kim H. The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases.Biomedicines. 2020;8:501. [PMID: 33207562 DOI: 10.3390/biomedicines8110501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
79 Jain AK, le Roux CW, Puri P, Tavakkoli A, Gletsu-Miller N, Laferrère B, Kellermayer R, DiBaise JK, Martindale RG, Wolfe BM. Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut. JPEN J Parenter Enteral Nutr 2018;42:279-95. [PMID: 29443403 DOI: 10.1002/jpen.1121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
80 Quinn RA, Melnik AV, Vrbanac A, Fu T, Patras KA, Christy MP, Bodai Z, Belda-Ferre P, Tripathi A, Chung LK, Downes M, Welch RD, Quinn M, Humphrey G, Panitchpakdi M, Weldon KC, Aksenov A, da Silva R, Avila-Pacheco J, Clish C, Bae S, Mallick H, Franzosa EA, Lloyd-Price J, Bussell R, Thron T, Nelson AT, Wang M, Leszczynski E, Vargas F, Gauglitz JM, Meehan MJ, Gentry E, Arthur TD, Komor AC, Poulsen O, Boland BS, Chang JT, Sandborn WJ, Lim M, Garg N, Lumeng JC, Xavier RJ, Kazmierczak BI, Jain R, Egan M, Rhee KE, Ferguson D, Raffatellu M, Vlamakis H, Haddad GG, Siegel D, Huttenhower C, Mazmanian SK, Evans RM, Nizet V, Knight R, Dorrestein PC. Global chemical effects of the microbiome include new bile-acid conjugations. Nature 2020;579:123-9. [PMID: 32103176 DOI: 10.1038/s41586-020-2047-9] [Cited by in Crossref: 85] [Cited by in F6Publishing: 58] [Article Influence: 85.0] [Reference Citation Analysis]
81 Devkota S, Turnbaugh PJ. Cancer: An acidic link. Nature. 2013;499:37-38. [PMID: 23803768 DOI: 10.1038/nature12404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
82 Cunningham AL, Stephens JW, Harris DA. Gut microbiota influence in type 2 diabetes mellitus (T2DM). Gut Pathog 2021;13:50. [PMID: 34362432 DOI: 10.1186/s13099-021-00446-0] [Reference Citation Analysis]
83 Dewar ML, Arnould JPY, Allnutt TR, Crowley T, Krause L, Reynolds J, Dann P, Smith SC. Microbiota of little penguins and short-tailed shearwaters during development. PLoS One 2017;12:e0183117. [PMID: 28806408 DOI: 10.1371/journal.pone.0183117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
84 Tran CD, Grice DM, Wade B, Kerr CA, Bauer DC, Li D, Hannan GN. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid. Future Microbiology 2015;10:1339-53. [DOI: 10.2217/fmb.15.54] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
85 Manthey C, Eckmann L, Fuhrmann V. Therapy for Clostridium difficile infection – any news beyond Metronidazole and Vancomycin? Expert Review of Clinical Pharmacology 2017;10:1239-50. [DOI: 10.1080/17512433.2017.1362978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
86 Martin FP, Collino S, Rezzi S, Kochhar S. Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front Physiol. 2012;3:113. [PMID: 22557976 DOI: 10.3389/fphys.2012.00113] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
87 Liu D, Li T, Zheng H, Yin X, Chen M, Liao Z, Hu M, Luo Z, Lu B, Li Y, Liao Q, Xie Z, Wu F. Study on alterations of physiological functions in aged constipation rats with fluid-deficiency based on metabonomic and microbiology analysis. RSC Adv 2017;7:48136-50. [DOI: 10.1039/c7ra07651g] [Cited by in Crossref: 14] [Article Influence: 3.5] [Reference Citation Analysis]
88 Montagner A, Korecka A, Polizzi A, Lippi Y, Blum Y, Canlet C, Tremblay-Franco M, Gautier-Stein A, Burcelin R, Yen YC, Je HS, Al-Asmakh M, Mithieux G, Arulampalam V, Lagarrigue S, Guillou H, Pettersson S, Wahli W. Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals. Sci Rep 2016;6:20127. [PMID: 26879573 DOI: 10.1038/srep20127] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 13.2] [Reference Citation Analysis]
89 Jayakumar S, Loomba R. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Aliment Pharmacol Ther 2019;50:144-58. [PMID: 31149745 DOI: 10.1111/apt.15314] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
90 Zhao L, Wang G, Siegel P, He C, Wang H, Zhao W, Zhai Z, Tian F, Zhao J, Zhang H. Quantitative genetic background of the host influences gut microbiomes in chickens. Sci Rep. 2013;3:1163. [PMID: 23362462 DOI: 10.1038/srep01163] [Cited by in Crossref: 166] [Cited by in F6Publishing: 149] [Article Influence: 20.8] [Reference Citation Analysis]
91 Bauer KC, Huus KE, Brown EM, Bozorgmehr T, Petersen C, Cirstea MS, Woodward SE, McCoy J, Hun J, Pamplona R, Ayala V, Finlay BB. Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition. mSystems 2020;5:e00499-20. [PMID: 32900869 DOI: 10.1128/mSystems.00499-20] [Reference Citation Analysis]
92 Semova I, Carten JD, Stombaugh J, Mackey LC, Knight R, Farber SA, Rawls JF. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe. 2012;12:277-288. [PMID: 22980325 DOI: 10.1016/j.chom.2012.08.003] [Cited by in Crossref: 417] [Cited by in F6Publishing: 310] [Article Influence: 52.1] [Reference Citation Analysis]
93 Fritz JV, Desai MS, Shah P, Schneider JG, Wilmes P. From meta-omics to causality: experimental models for human microbiome research. Microbiome 2013;1:14. [PMID: 24450613 DOI: 10.1186/2049-2618-1-14] [Cited by in Crossref: 107] [Cited by in F6Publishing: 77] [Article Influence: 13.4] [Reference Citation Analysis]
94 Han J, Qin WX, Li ZL, Xu AJ, Xing H, Wu H, Zhang H, Wang MD, Li C, Liang L, Quan B, Yan WT, Shen F, Wu MC, Yang T. Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Chim Acta 2019;488:68-75. [PMID: 30389456 DOI: 10.1016/j.cca.2018.10.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
95 Li H, Jia W. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther. 2013;94:574-581. [PMID: 23933971 DOI: 10.1038/clpt.2013.157] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
96 Lach G, Schellekens H, Dinan TG, Cryan JF. Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. Neurotherapeutics. 2018;15:36-59. [PMID: 29134359 DOI: 10.1007/s13311-017-0585-0] [Cited by in Crossref: 170] [Cited by in F6Publishing: 128] [Article Influence: 85.0] [Reference Citation Analysis]
97 Hartmann P, Chu H, Duan Y, Schnabl B. Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either. Am J Physiol Gastrointest Liver Physiol 2019;316:G563-73. [PMID: 30767680 DOI: 10.1152/ajpgi.00370.2018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 13.5] [Reference Citation Analysis]
98 Tian Y, Wang H, Yuan F, Li N, Huang Q, He L, Wang L, Liu Z. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis. Biomed Res Int 2016;2016:9462571. [PMID: 27051672 DOI: 10.1155/2016/9462571] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
99 Cho Y, Osgood RS, Bell LN, Karoly ED, Shore SA. Ozone-induced changes in the serum metabolome: Role of the microbiome. PLoS One 2019;14:e0221633. [PMID: 31454377 DOI: 10.1371/journal.pone.0221633] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
100 Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut 2014;63:1513-21. [DOI: 10.1136/gutjnl-2014-306928] [Cited by in Crossref: 389] [Cited by in F6Publishing: 318] [Article Influence: 55.6] [Reference Citation Analysis]
101 Cullen JM, Faiola B, Melich DH, Peterson RA, Jordan HL, Kimbrough CL, Miller RT. Acute Alpha-Naphthylisothiocyanate-induced Liver Toxicity in Germfree and Conventional Male Rats. Toxicol Pathol 2016;44:987-97. [PMID: 27519817 DOI: 10.1177/0192623316662360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
102 Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. J Exp Med 2018;215:383-96. [PMID: 29339445 DOI: 10.1084/jem.20171965] [Cited by in Crossref: 127] [Cited by in F6Publishing: 102] [Article Influence: 42.3] [Reference Citation Analysis]
103 Chang EB, Martinez-Guryn K. Small intestinal microbiota: the neglected stepchild needed for fat digestion and absorption. Gut Microbes 2019;10:235-40. [PMID: 30136893 DOI: 10.1080/19490976.2018.1502539] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
104 Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014;20:16079-16094. [PMID: 25473159 DOI: 10.3748/wjg.v20.i43.16079] [Cited by in CrossRef: 221] [Cited by in F6Publishing: 172] [Article Influence: 36.8] [Reference Citation Analysis]
105 Li T, Chiang JY. Bile acids as metabolic regulators. Curr Opin Gastroenterol 2015;31:159-65. [PMID: 25584736 DOI: 10.1097/MOG.0000000000000156] [Cited by in Crossref: 154] [Cited by in F6Publishing: 65] [Article Influence: 25.7] [Reference Citation Analysis]
106 . Milk modulates the microbiota. Nat Med 2012;18:1186-7. [DOI: 10.1038/nm.2902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Zhou R, Fan X, Schnabl B. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Transl Res 2019;209:22-38. [PMID: 30853445 DOI: 10.1016/j.trsl.2019.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
108 Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, Hill C, Gahan CG. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci USA. 2014;111:7421-7426. [PMID: 24799697 DOI: 10.1073/pnas.1323599111] [Cited by in Crossref: 301] [Cited by in F6Publishing: 245] [Article Influence: 43.0] [Reference Citation Analysis]
109 Bustos AY, Font de Valdez G, Fadda S, Taranto MP. New insights into bacterial bile resistance mechanisms: the role of bile salt hydrolase and its impact on human health. Food Research International 2018;112:250-62. [DOI: 10.1016/j.foodres.2018.06.035] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
110 Chang S, Song N, Choi JH, Yun UJ, Park KW. Mechanisms underlying UCP1 dependent and independent adipocyte thermogenesis. Obesity Reviews 2019;20:241-51. [DOI: 10.1111/obr.12796] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 7.7] [Reference Citation Analysis]
111 Romano-Keeler J, Zhang J, Sun J. The Life-Long Role of Nutrition on the Gut Microbiome and Gastrointestinal Disease. Gastroenterol Clin North Am 2021;50:77-100. [PMID: 33518170 DOI: 10.1016/j.gtc.2020.10.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Chi L, Tu P, Ru H, Lu K. Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms. Gut Microbes 2021;13:1921912. [PMID: 34313531 DOI: 10.1080/19490976.2021.1921912] [Reference Citation Analysis]
113 Fader KA, Nault R, Zhang C, Kumagai K, Harkema JR, Zacharewski TR. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: Alterations in biosynthesis, enterohepatic circulation, and microbial metabolism. Sci Rep 2017;7:5921. [PMID: 28725001 DOI: 10.1038/s41598-017-05656-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
114 Khalsa J, Duffy LC, Riscuta G, Starke-reed P, Hubbard VS. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine. Clinical Pharmacology in Drug Development 2017;6:176-85. [DOI: 10.1002/cpdd.310] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
115 Postler TS, Ghosh S. Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System. Cell Metab 2017;26:110-30. [PMID: 28625867 DOI: 10.1016/j.cmet.2017.05.008] [Cited by in Crossref: 302] [Cited by in F6Publishing: 232] [Article Influence: 75.5] [Reference Citation Analysis]
116 Hollinshead KE, Williams DS, Tennant DA, Ludwig C. Probing Cancer Cell Metabolism Using NMR Spectroscopy. Adv Exp Med Biol 2016;899:89-111. [PMID: 27325263 DOI: 10.1007/978-3-319-26666-4_6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
117 Safari Z, Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci 2019;76:1541-58. [PMID: 30683985 DOI: 10.1007/s00018-019-03011-w] [Cited by in Crossref: 101] [Cited by in F6Publishing: 76] [Article Influence: 50.5] [Reference Citation Analysis]
118 Masetti R, Zama D, Leardini D, Muratore E, Turroni S, Brigidi P, Pession A. Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation. Int J Mol Sci 2021;22:1197. [PMID: 33530464 DOI: 10.3390/ijms22031197] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, Takei H, Muto A, Nittono H, Ridlon JM, White MB, Noble NA, Monteith P, Fuchs M, Thacker LR, Sikaroodi M, Bajaj JS. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol 2013;58:949-55. [PMID: 23333527 DOI: 10.1016/j.jhep.2013.01.003] [Cited by in Crossref: 359] [Cited by in F6Publishing: 322] [Article Influence: 44.9] [Reference Citation Analysis]
120 Theriot CM, Young VB. Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol 2015;69:445-61. [PMID: 26488281 DOI: 10.1146/annurev-micro-091014-104115] [Cited by in Crossref: 163] [Cited by in F6Publishing: 116] [Article Influence: 32.6] [Reference Citation Analysis]
121 Ipharraguerre IR, Pastor JJ, Gavaldà-Navarro A, Villarroya F, Mereu A. Antimicrobial promotion of pig growth is associated with tissue-specific remodeling of bile acid signature and signaling. Sci Rep 2018;8:13671. [PMID: 30209339 DOI: 10.1038/s41598-018-32107-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
122 Sun J, Schnackenberg LK, Khare S, Yang X, Greenhaw J, Salminen W, Mendrick DL, Beger RD. Evaluating effects of penicillin treatment on the metabolome of rats. J Chromatogr B Analyt Technol Biomed Life Sci 2013;932:134-43. [PMID: 23831706 DOI: 10.1016/j.jchromb.2013.05.030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
123 Daliri EB, Wei S, Oh DH, Lee BH. The human microbiome and metabolomics: Current concepts and applications. Crit Rev Food Sci Nutr 2017;57:3565-76. [PMID: 27767329 DOI: 10.1080/10408398.2016.1220913] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
124 Reuter B, Bajaj JS. Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.Clin Liver Dis. 2020;24:493-520. [PMID: 32620285 DOI: 10.1016/j.cld.2020.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Jones ML, Ganopolsky JG, Martoni CJ, Labbé A, Prakash S. Emerging science of the human microbiome. Gut Microbes 2014;5:446-57. [PMID: 25013912 DOI: 10.4161/gmic.29810] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
126 Xie G, Zhong W, Li H, Li Q, Qiu Y, Zheng X, Chen H, Zhao X, Zhang S, Zhou Z, Zeisel SH, Jia W. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J. 2013;27:3583-3593. [PMID: 23709616 DOI: 10.1096/fj.13-231860] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 13.5] [Reference Citation Analysis]
127 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-691] [Reference Citation Analysis]
128 Ren G, Zhang J, Li M, Tang Z, Yang Z, Cheng G, Wang J. Gut microbiota composition influences outcomes of skeletal muscle nutritional intervention via blended protein supplementation in posttransplant patients with hematological malignancies. Clin Nutr 2021;40:94-102. [PMID: 32402683 DOI: 10.1016/j.clnu.2020.04.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
129 Nolan JA, Skuse P, Govindarajan K, Patterson E, Konstantinidou N, Casey PG, MacSharry J, Shanahan F, Stanton C, Hill C, Cotter PD, Joyce SA, Gahan CGM. The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles. Am J Physiol Gastrointest Liver Physiol 2017;312:G488-97. [PMID: 28209601 DOI: 10.1152/ajpgi.00149.2016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
130 Jin Y, Wu Y, Zeng Z, Jin C, Wu S, Wang Y, Fu Z. From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice. Toxicol Sci 2016;154:140-52. [DOI: 10.1093/toxsci/kfw150] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
131 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 20.0] [Reference Citation Analysis]
132 Wang X, Xie G, Zhao A, Zheng X, Huang F, Wang Y, Yao C, Jia W, Liu P. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis. J Proteome Res 2016;15:1126-34. [PMID: 25964117 DOI: 10.1021/acs.jproteome.5b00217] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
133 Shapiro H, Suez J, Elinav E. Personalized microbiome-based approaches to metabolic syndrome management and prevention. J Diabetes 2017;9:226-36. [PMID: 27787945 DOI: 10.1111/1753-0407.12501] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
134 Chen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, Zhu JD, Zhang QY, Mi MT. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. MBio. 2016;7:e02210-e02215. [PMID: 27048804 DOI: 10.1128/mbio.02210-15] [Cited by in Crossref: 242] [Cited by in F6Publishing: 133] [Article Influence: 48.4] [Reference Citation Analysis]
135 Jena PK, Sheng L, Di Lucente J, Jin LW, Maezawa I, Wan YY. Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity. FASEB J. 2018;32:2866-2877. [PMID: 29401580 DOI: 10.1096/fj.201700984rr] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 12.7] [Reference Citation Analysis]
136 Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013;17:225-35. [PMID: 23395169 DOI: 10.1016/j.cmet.2013.01.003] [Cited by in Crossref: 1040] [Cited by in F6Publishing: 906] [Article Influence: 130.0] [Reference Citation Analysis]
137 Kuipers F, Bloks VW, Groen AK. Beyond intestinal soap--bile acids in metabolic control. Nat Rev Endocrinol. 2014;10:488-498. [PMID: 24821328 DOI: 10.1038/nrendo.2014.60] [Cited by in Crossref: 251] [Cited by in F6Publishing: 223] [Article Influence: 35.9] [Reference Citation Analysis]
138 Liu HX, Keane R, Sheng L, Wan YJ. Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol. 2015;63:1502-1510. [PMID: 26256437 DOI: 10.1016/j.jhep.2015.08.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
139 McGlone ER, Bloom SR. Bile acids and the metabolic syndrome. Ann Clin Biochem 2019;56:326-37. [PMID: 30453753 DOI: 10.1177/0004563218817798] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
140 Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 2014;30:332-338. [PMID: 24625896 DOI: 10.1097/mog.0000000000000057] [Cited by in Crossref: 556] [Cited by in F6Publishing: 296] [Article Influence: 79.4] [Reference Citation Analysis]
141 Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, Lindon JC. Metabolic phenotyping in clinical and surgical environments. Nature. 2012;491:384-392. [PMID: 23151581 DOI: 10.1038/nature11708] [Cited by in Crossref: 318] [Cited by in F6Publishing: 240] [Article Influence: 35.3] [Reference Citation Analysis]
142 Nie B, Park HM, Kazantzis M, Lin M, Henkin A, Ng S, Song S, Chen Y, Tran H, Lai R, Her C, Maher JJ, Forman BM, Stahl A. Specific bile acids inhibit hepatic fatty acid uptake in mice. Hepatology 2012;56:1300-10. [PMID: 22531947 DOI: 10.1002/hep.25797] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
143 Xie G, Zhang S, Zheng X, Jia W. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes. Electrophoresis 2013;34:2787-98. [PMID: 23775228 DOI: 10.1002/elps.201300017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
144 Johnson CH, Gonzalez FJ. Challenges and opportunities of metabolomics. J Cell Physiol 2012;227:2975-81. [PMID: 22034100 DOI: 10.1002/jcp.24002] [Cited by in Crossref: 137] [Cited by in F6Publishing: 100] [Article Influence: 15.2] [Reference Citation Analysis]
145 Kirpich IA, Parajuli D, McClain CJ. Microbiome in NAFLD and ALD. Clin Liver Dis (Hoboken) 2015;6:55-8. [PMID: 26576267 DOI: 10.1002/cld.494] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
146 Fu ZD, Cui JY. Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites. Curr Pharmacol Rep 2017;3:101-13. [PMID: 28983453 DOI: 10.1007/s40495-017-0087-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
147 Walker A, Pfitzner B, Neschen S, Kahle M, Harir M, Lucio M, Moritz F, Tziotis D, Witting M, Rothballer M, Engel M, Schmid M, Endesfelder D, Klingenspor M, Rattei T, Castell WZ, de Angelis MH, Hartmann A, Schmitt-Kopplin P. Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. ISME J 2014;8:2380-96. [PMID: 24906017 DOI: 10.1038/ismej.2014.79] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 11.9] [Reference Citation Analysis]
148 Acharya C, Bajaj JS. Altered Microbiome in Patients With Cirrhosis and Complications. Clin Gastroenterol Hepatol 2019;17:307-21. [PMID: 30099098 DOI: 10.1016/j.cgh.2018.08.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 15.3] [Reference Citation Analysis]
149 Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336:1262-1267. [PMID: 22674330 DOI: 10.1126/science.1223813] [Cited by in Crossref: 2386] [Cited by in F6Publishing: 1921] [Article Influence: 265.1] [Reference Citation Analysis]
150 Wei X, Jiang S, Zhao X, Li H, Lin W, Li B, Lu J, Sun Y, Yuan J. Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients. Front Microbiol 2016;7:1856. [PMID: 27899923 DOI: 10.3389/fmicb.2016.01856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
151 Alemán JO, Bokulich NA, Swann JR, Walker JM, De Rosa JC, Battaglia T, Costabile A, Pechlivanis A, Liang Y, Breslow JL, Blaser MJ, Holt PR. Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women. J Transl Med 2018;16:244. [PMID: 30176893 DOI: 10.1186/s12967-018-1619-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
152 Ju T, Kong JY, Stothard P, Willing BP. Defining the role of Parasutterella, a previously uncharacterized member of the core gut microbiota. ISME J 2019;13:1520-34. [PMID: 30742017 DOI: 10.1038/s41396-019-0364-5] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 30.5] [Reference Citation Analysis]
153 Shively CA, Register TC, Appt SE, Clarkson TB, Uberseder B, Clear KYJ, Wilson AS, Chiba A, Tooze JA, Cook KL. Consumption of Mediterranean versus Western Diet Leads to Distinct Mammary Gland Microbiome Populations. Cell Rep 2018;25:47-56.e3. [PMID: 30282037 DOI: 10.1016/j.celrep.2018.08.078] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 51.0] [Reference Citation Analysis]
154 Cunningham AL, Stephens JW, Harris DA. A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids Health Dis 2021;20:65. [PMID: 34233682 DOI: 10.1186/s12944-021-01491-z] [Reference Citation Analysis]
155 Zhang X, Wang Y, Zhong M, Liu T, Han H, Zhang G, Liu S, Wei M, Wu Q, Hu S. Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model. OBES SURG 2016;26:1890-9. [DOI: 10.1007/s11695-015-2031-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
156 Sanduzzi Zamparelli M, Compare D, Coccoli P, Rocco A, Nardone OM, Marrone G, Gasbarrini A, Grieco A, Nardone G, Miele L. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Int J Mol Sci. 2016;17. [PMID: 27483246 DOI: 10.3390/ijms17081225] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
157 Moran C, Sheehan D, Shanahan F. The small bowel microbiota. Curr Opin Gastroenterol 2015;31:130-6. [PMID: 25603402 DOI: 10.1097/MOG.0000000000000157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
158 Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-9. [PMID: 22972297 DOI: 10.1038/nature11552] [Reference Citation Analysis]
159 Gao B, Chi L, Mahbub R, Bian X, Tu P, Ru H, Lu K. Multi-Omics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites, and Metabolic Pathways. Chem Res Toxicol 2017;30:996-1005. [PMID: 28234468 DOI: 10.1021/acs.chemrestox.6b00401] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
160 Hua YL, Jia YQ, Zhang XS, Yuan ZW, Ji P, Hu JJ, Wei YM. Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5. Biomed Pharmacother 2021;137:111320. [PMID: 33578232 DOI: 10.1016/j.biopha.2021.111320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Shore SA, Cho Y. Obesity and Asthma: Microbiome-Metabolome Interactions. Am J Respir Cell Mol Biol 2016;54:609-17. [PMID: 26949916 DOI: 10.1165/rcmb.2016-0052PS] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 10.8] [Reference Citation Analysis]
162 Ferreira RDS, Mendonça LABM, Ribeiro CFA, Calças NC, Guimarães RCA, Nascimento VAD, Gielow KCF, Carvalho CME, Castro AP, Franco OL. Relationship between intestinal microbiota, diet and biological systems: an integrated view. Crit Rev Food Sci Nutr 2020;:1-21. [PMID: 33115284 DOI: 10.1080/10408398.2020.1836605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
163 Wang X, Zhang Y, Wen Q, Wang Y, Wang Z, Tan Z, Wu K. Sex Differences in Intestinal Microbial Composition and Function of Hainan Special Wild Boar. Animals (Basel) 2020;10:E1553. [PMID: 32887230 DOI: 10.3390/ani10091553] [Reference Citation Analysis]
164 Di Ciaula A, Wang DQ, Molina-Molina E, Lunardi Baccetto R, Calamita G, Palmieri VO, Portincasa P. Bile Acids and Cancer: Direct and Environmental-Dependent Effects. Ann Hepatol 2017;16:s87-s105. [PMID: 29080344 DOI: 10.5604/01.3001.0010.5501] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
165 Rojo D, Gosalbes MJ, Ferrari R, Pérez-Cobas AE, Hernández E, Oltra R, Buesa J, Latorre A, Barbas C, Ferrer M, Moya A. Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses. ISME J 2015;9:2206-20. [PMID: 25756679 DOI: 10.1038/ismej.2015.32] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
166 Xue Y, Ma C, Hanna I, Pan G. Intestinal Transporter-Associated Drug Absorption and Toxicity. In: Liu X, Pan G, editors. Drug Transporters in Drug Disposition, Effects and Toxicity. Singapore: Springer; 2019. pp. 361-405. [DOI: 10.1007/978-981-13-7647-4_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
167 Tolnai E, Fauszt P, Fidler G, Pesti-Asboth G, Szilagyi E, Stagel A, Konya J, Szabo J, Stundl L, Babinszky L, Remenyik J, Biro S, Paholcsek M. Nutraceuticals Induced Changes in the Broiler Gastrointestinal Tract Microbiota. mSystems 2021;6:e01124-20. [PMID: 33653943 DOI: 10.1128/mSystems.01124-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Roager HM, Sulek K, Skov K, Frandsen HL, Smedsgaard J, Wilcks A, Skov TH, Villas-Boas SG, Licht TR. Lactobacillus acidophilus NCFM affects vitamin E acetate metabolism and intestinal bile acid signature in monocolonized mice. Gut Microbes 2014;5:296-303. [PMID: 24717228 DOI: 10.4161/gmic.28806] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
169 Urdaneta V, Casadesús J. Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts. Front Med (Lausanne) 2017;4:163. [PMID: 29043249 DOI: 10.3389/fmed.2017.00163] [Cited by in Crossref: 115] [Cited by in F6Publishing: 72] [Article Influence: 28.8] [Reference Citation Analysis]
170 Griffin BA, Mensink RP, Lovegrove JA. Does variation in serum LDL-cholesterol response to dietary fatty acids help explain the controversy over fat quality and cardiovascular disease risk? Atherosclerosis 2021;328:108-13. [PMID: 33863548 DOI: 10.1016/j.atherosclerosis.2021.03.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Jin M, Pan T, Cheng X, Zhu TT, Sun P, Zhou F, Ding X, Zhou Q. Effects of supplemental dietary l-carnitine and bile acids on growth performance, antioxidant and immune ability, histopathological changes and inflammatory response in juvenile black seabream (Acanthopagrus schlegelii) fed high-fat diet. Aquaculture 2019;504:199-209. [DOI: 10.1016/j.aquaculture.2019.01.063] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
172 Luan H, Wang X, Cai Z. Mass spectrometry‐based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders. Mass Spec Rev 2017;38:22-33. [DOI: 10.1002/mas.21553] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 11.5] [Reference Citation Analysis]
173 Moran CP, Shanahan F. Gut microbiota and obesity: role in aetiology and potential therapeutic target. Best Pract Res Clin Gastroenterol. 2014;28:585-597. [PMID: 25194177 DOI: 10.1016/j.bpg.2014.07.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 9.1] [Reference Citation Analysis]
174 Nakamoto N, Schnabl B. Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West? Inflamm Intest Dis. 2016;1:3-8. [PMID: 27243019 DOI: 10.1159/000443196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
175 van Olst N, Meiring S, de Brauw M, Bergman JJ, Nieuwdorp M, van der Peet DL, Gerdes VE. Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome. Techniques and Innovations in Gastrointestinal Endoscopy 2020;22:109-19. [DOI: 10.1016/j.tige.2020.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
176 El Aidy S, Stilling R, Dinan TG, Cryan JF. Microbiome to Brain: Unravelling the Multidirectional Axes of Communication. Adv Exp Med Biol 2016;874:301-36. [PMID: 26589226 DOI: 10.1007/978-3-319-20215-0_15] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
177 Cheng M, Cao L, Ning K. Microbiome Big-Data Mining and Applications Using Single-Cell Technologies and Metagenomics Approaches Toward Precision Medicine. Front Genet 2019;10:972. [PMID: 31649735 DOI: 10.3389/fgene.2019.00972] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
178 Brandi G, De Lorenzo S, Candela M, Pantaleo MA, Bellentani S, Tovoli F, Saccoccio G, Biasco G. Microbiota, NASH, HCC and the potential role of probiotics. Carcinogenesis 2017;38:231-40. [DOI: 10.1093/carcin/bgx007] [Cited by in Crossref: 104] [Cited by in F6Publishing: 44] [Article Influence: 26.0] [Reference Citation Analysis]
179 Udayappan S, Manneras-Holm L, Chaplin-Scott A, Belzer C, Herrema H, Dallinga-Thie GM, Duncan SH, Stroes ESG, Groen AK, Flint HJ, Backhed F, de Vos WM, Nieuwdorp M. Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms Microbiomes. 2016;2:16009. [PMID: 28721246 DOI: 10.1038/npjbiofilms.2016.9] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 15.6] [Reference Citation Analysis]
180 Wewalka M, Patti ME, Barbato C, Houten SM, Goldfine AB. Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. J Clin Endocrinol Metab. 2014;99:1442-1451. [PMID: 24432996 DOI: 10.1210/jc.2013-3367] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 10.9] [Reference Citation Analysis]
181 Bordoni A, Amaretti A, Leonardi A, Boschetti E, Danesi F, Matteuzzi D, Roncaglia L, Raimondi S, Rossi M. Cholesterol-lowering probiotics: In vitro selection and in vivo testing of bifidobacteria. Appl Microbiol Biotechnol. 2013;97:8273-8281. [PMID: 23872958 DOI: 10.1007/s00253-013-5088-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
182 Gao S, Yang R, Peng Z, Lu H, Li N, Ding J, Cui X, Chen W, Dong X. Metabolomics analysis for hydroxy-L-proline-induced calcium oxalate nephrolithiasis in rats based on ultra-high performance liquid chromatography quadrupole time-of-flight mass spectrometry. Sci Rep 2016;6:30142. [PMID: 27443631 DOI: 10.1038/srep30142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
183 Sivamaruthi BS, Kesika P, Suganthy N, Chaiyasut C. A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements. Biomed Res Int 2019;2019:3291367. [PMID: 31211135 DOI: 10.1155/2019/3291367] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 23.0] [Reference Citation Analysis]
184 Wilson A, Almousa A, Teft WA, Kim RB. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease. Sci Rep 2020;10:1866. [PMID: 32024859 DOI: 10.1038/s41598-020-58644-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
185 Pereira-Fantini PM, Lapthorne S, Gahan CGM, Joyce SA, Charles J, Fuller PJ, Bines JE. Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome. Cell Mol Gastroenterol Hepatol 2017;4:65-74. [PMID: 28560290 DOI: 10.1016/j.jcmgh.2017.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
186 Yip LY, Chan EC. Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome. Drug Metab Dispos 2015;43:1619-31. [PMID: 25979259 DOI: 10.1124/dmd.115.063750] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
187 Hassouneh R, Bajaj JS. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment. J Clin Med 2021;10:330. [PMID: 33477417 DOI: 10.3390/jcm10020330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
188 Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15:111-128. [PMID: 29018272 DOI: 10.1038/nrgastro.2017.119] [Cited by in Crossref: 339] [Cited by in F6Publishing: 278] [Article Influence: 84.8] [Reference Citation Analysis]
189 Harrison CA, Taren D. How poverty affects diet to shape the microbiota and chronic disease. Nat Rev Immunol 2018;18:279-87. [PMID: 29109542 DOI: 10.1038/nri.2017.121] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
190 Bindels LB, Segura Munoz RR, Gomes-Neto JC, Mutemberezi V, Martínez I, Salazar N, Cody EA, Quintero-Villegas MI, Kittana H, de Los Reyes-Gavilán CG, Schmaltz RJ, Muccioli GG, Walter J, Ramer-Tait AE. Resistant starch can improve insulin sensitivity independently of the gut microbiota. Microbiome 2017;5:12. [PMID: 28166818 DOI: 10.1186/s40168-017-0230-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 16.5] [Reference Citation Analysis]
191 Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun. 2013;4:2384. [PMID: 24064762 DOI: 10.1038/ncomms3384] [Cited by in Crossref: 347] [Cited by in F6Publishing: 319] [Article Influence: 49.6] [Reference Citation Analysis]
192 Yang JY, Kweon MN. The gut microbiota: a key regulator of metabolic diseases. BMB Rep 2016;49:536-41. [PMID: 27530685 DOI: 10.5483/bmbrep.2016.49.10.144] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
193 Mu C, Zhu W. Antibiotic effects on gut microbiota, metabolism, and beyond. Appl Microbiol Biotechnol. 2019;103:9277-9285. [PMID: 31701196 DOI: 10.1007/s00253-019-10165-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
194 Penney NC, Kinross J, Newton RC, Purkayastha S. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes (Lond). 2015;39:1565-1574. [PMID: 26081915 DOI: 10.1038/ijo.2015.115] [Cited by in Crossref: 90] [Cited by in F6Publishing: 72] [Article Influence: 15.0] [Reference Citation Analysis]
195 Ran L, Liu AB, Lee M, Xie P, Lin Y, Yang CS. Effects of antibiotics on degradation and bioavailability of different vitamin E forms in mice. BioFactors 2019;45:450-62. [DOI: 10.1002/biof.1492] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
196 Ruoppolo M, Caterino M, Albano L, Pecce R, Di Girolamo MG, Crisci D, Costanzo M, Milella L, Franconi F, Campesi I. Targeted metabolomic profiling in rat tissues reveals sex differences. Sci Rep 2018;8:4663. [PMID: 29549307 DOI: 10.1038/s41598-018-22869-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
197 Xiong F, Wu SG, Zhang J, Jakovlić I, Li WX, Zou H, Li M, Wang GT. Dietary Bile Salt Types Influence the Composition of Biliary Bile Acids and Gut Microbiota in Grass Carp. Front Microbiol 2018;9:2209. [PMID: 30279683 DOI: 10.3389/fmicb.2018.02209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
198 Holmes E, Wijeyesekera A, Taylor-Robinson SD, Nicholson JK. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2015;12:458-71. [PMID: 26194948 DOI: 10.1038/nrgastro.2015.114] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
199 Qiao S, Bao L, Wang K, Sun S, Liao M, Liu C, Zhou N, Ma K, Zhang Y, Chen Y, Liu SJ, Liu H. Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis. Cell Rep. 2020;32:108005. [PMID: 32783933 DOI: 10.1016/j.celrep.2020.108005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
200 Wegner K, Just S, Gau L, Mueller H, Gérard P, Lepage P, Clavel T, Rohn S. Rapid analysis of bile acids in different biological matrices using LC-ESI-MS/MS for the investigation of bile acid transformation by mammalian gut bacteria. Anal Bioanal Chem 2017;409:1231-45. [PMID: 27822648 DOI: 10.1007/s00216-016-0048-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
201 Janssen AWF, Kersten S. The role of the gut microbiota in metabolic health. The FASEB Journal 2015;29:3111-23. [DOI: 10.1096/fj.14-269514] [Cited by in Crossref: 99] [Cited by in F6Publishing: 77] [Article Influence: 16.5] [Reference Citation Analysis]
202 Smiljanec K, Lennon SL. Sodium, hypertension, and the gut: does the gut microbiota go salty? Am J Physiol Heart Circ Physiol 2019;317:H1173-82. [PMID: 31585045 DOI: 10.1152/ajpheart.00312.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
203 Kilburn LR, Koester LR, Schmitz-Esser S, Serão NVL, Rossoni Serão MC. High-Fat Diets Led to OTU-Level Shifts in Fecal Samples of Healthy Adult Dogs. Front Microbiol 2020;11:564160. [PMID: 33363518 DOI: 10.3389/fmicb.2020.564160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut. Dig Dis 2015;33:338-45. [PMID: 26045267 DOI: 10.1159/000371678] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 8.5] [Reference Citation Analysis]
205 Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L, Alnouti Y, Fouts DE, Stärkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L, Rossi SJ, DePaoli AM, Downes M, Evans RM, Brenner DA, Schnabl B. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology 2018;67:2150-66. [PMID: 29159825 DOI: 10.1002/hep.29676] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 33.0] [Reference Citation Analysis]
206 Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-9. [DOI: 10.1038/nature11552] [Cited by in Crossref: 2354] [Cited by in F6Publishing: 1935] [Article Influence: 261.6] [Reference Citation Analysis]
207 Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014;66:948-83. [PMID: 25073467 DOI: 10.1124/pr.113.008201] [Cited by in Crossref: 402] [Cited by in F6Publishing: 336] [Article Influence: 67.0] [Reference Citation Analysis]
208 Zhong MW, Liu SZ, Zhang GY, Zhang X, Liu T, Hu SY. Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats. World J Gastroenterol. 2016;22:6706-6715. [PMID: 27547013 DOI: 10.3748/wjg.v22.i29.6706] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
209 Joyce SA, Shanahan F, Hill C, Gahan CG. Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk. Gut Microbes 2014;5:669-74. [PMID: 25483337 DOI: 10.4161/19490976.2014.969986] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 10.8] [Reference Citation Analysis]
210 Betrapally NS, Gillevet PM, Bajaj JS. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? Gastroenterology 2016;150:1745-1755.e3. [PMID: 26948887 DOI: 10.1053/j.gastro.2016.02.073] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 14.6] [Reference Citation Analysis]
211 Forgie AJ, Drall KM, Bourque SL, Field CJ, Kozyrskyj AL, Willing BP. The impact of maternal and early life malnutrition on health: a diet-microbe perspective. BMC Med 2020;18:135. [PMID: 32393275 DOI: 10.1186/s12916-020-01584-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
212 Chakraborti CK. New-found link between microbiota and obesity. World J Gastrointest Pathophysiol 2015;6:110-9. [PMID: 26600968 DOI: 10.4291/wjgp.v6.i4.110] [Cited by in CrossRef: 156] [Cited by in F6Publishing: 135] [Article Influence: 26.0] [Reference Citation Analysis]
213 Blais EM, Rawls KD, Dougherty BV, Li ZI, Kolling GL, Ye P, Wallqvist A, Papin JA. Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. Nat Commun 2017;8:14250. [PMID: 28176778 DOI: 10.1038/ncomms14250] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 19.8] [Reference Citation Analysis]
214 Zawada A, Rychter AM, Ratajczak AE, Lisiecka-Masian A, Dobrowolska A, Krela-Kaźmierczak I. Does Gut-Microbiome Interaction Protect against Obesity and Obesity-Associated Metabolic Disorders? Microorganisms 2020;9:E18. [PMID: 33374597 DOI: 10.3390/microorganisms9010018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
215 Evans JM, Morris LS, Marchesi JR. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol. 2013;218:R37-R47. [PMID: 23833275 DOI: 10.1530/joe-13-0131] [Cited by in Crossref: 118] [Cited by in F6Publishing: 56] [Article Influence: 14.8] [Reference Citation Analysis]
216 Aw W, Fukuda S. An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases. Diseases 2015;3:341-59. [PMID: 28943629 DOI: 10.3390/diseases3040341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
217 Burgess SL, Gilchrist CA, Lynn TC, Petri WA Jr. Parasitic Protozoa and Interactions with the Host Intestinal Microbiota. Infect Immun 2017;85:e00101-17. [PMID: 28584161 DOI: 10.1128/IAI.00101-17] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
218 Joshi-Barve S, Kirpich I, Cave MC, Marsano LS, McClain CJ. Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. Cell Mol Gastroenterol Hepatol 2015;1:356-67. [PMID: 28210688 DOI: 10.1016/j.jcmgh.2015.05.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
219 Hedin CRH, Vavricka SR, Stagg AJ, Schoepfer A, Raine T, Puig L, Pleyer U, Navarini A, van der Meulen-de Jong AE, Maul J, Katsanos K, Kagramanova A, Greuter T, González-Lama Y, van Gaalen F, Ellul P, Burisch J, Bettenworth D, Becker MD, Bamias G, Rieder F. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy. J Crohns Colitis 2019;13:541-54. [PMID: 30445584 DOI: 10.1093/ecco-jcc/jjy191] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 33.0] [Reference Citation Analysis]
220 Zhou SS, Xu J, Zhu H, Wu J, Xu JD, Yan R, Li XY, Liu HH, Duan SM, Wang Z, Chen HB, Shen H, Li SL. Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction. Sci Rep 2016;6:22474. [PMID: 26932472 DOI: 10.1038/srep22474] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 15.2] [Reference Citation Analysis]
221 Deng P, Swanson KS. Gut microbiota of humans, dogs and cats: current knowledge and future opportunities and challenges. Br J Nutr 2015;113 Suppl:S6-17. [PMID: 25414978 DOI: 10.1017/S0007114514002943] [Cited by in Crossref: 78] [Cited by in F6Publishing: 49] [Article Influence: 11.1] [Reference Citation Analysis]
222 Chen Q, Liu M, Zhang P, Fan S, Huang J, Yu S, Zhang C, Li H. Fucoidan and galactooligosaccharides ameliorate high-fat diet–induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism. Nutrition 2019;65:50-9. [DOI: 10.1016/j.nut.2019.03.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 20.5] [Reference Citation Analysis]
223 Yao L, Seaton SC, Ndousse-Fetter S, Adhikari AA, DiBenedetto N, Mina AI, Banks AS, Bry L, Devlin AS. A selective gut bacterial bile salt hydrolase alters host metabolism. Elife 2018;7:e37182. [PMID: 30014852 DOI: 10.7554/eLife.37182] [Cited by in Crossref: 71] [Cited by in F6Publishing: 50] [Article Influence: 23.7] [Reference Citation Analysis]
224 Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Pérez HE, Sandoval DA, Kohli R, Bäckhed F. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509:183-188. [PMID: 24670636 DOI: 10.1038/nature13135] [Cited by in Crossref: 630] [Cited by in F6Publishing: 520] [Article Influence: 90.0] [Reference Citation Analysis]
225 Fernández-Murga ML, Petrov PD, Conde I, Castell JV, Goméz-Lechón MJ, Jover R. Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems. Food Chem Toxicol 2018;120:196-212. [PMID: 29990576 DOI: 10.1016/j.fct.2018.07.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
226 Harsch IA, Konturek PC. The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases. Med Sci (Basel). 2018;6:pii: E3. [PMID: 29673211 DOI: 10.3390/medsci6020032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
227 Peng X, Yan C, Hu L, Huang Y, Fang Z, Lin Y, Xu S, Feng B, Li J, Zhuo Y, Wu, Che L. Live yeast supplementation during late gestation and lactation affects reproductive performance, colostrum and milk composition, blood biochemical and immunological parameters of sows. Anim Nutr 2020;6:288-92. [PMID: 33005762 DOI: 10.1016/j.aninu.2020.03.001] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Ryan PM, Stolte EH, London LEE, Wells JM, Long SL, Joyce SA, Gahan CGM, Fitzgerald GF, Ross RP, Caplice NM, Stanton C. Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbe. BMC Microbiol 2019;19:33. [PMID: 30736731 DOI: 10.1186/s12866-019-1403-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
229 Li R, Wang H, Shi Q, Wang N, Zhang Z, Xiong C, Liu J, Chen Y, Jiang L, Jiang Q. Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice. PLoS One 2017;12:e0181690. [PMID: 28742883 DOI: 10.1371/journal.pone.0181690] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
230 Li Q, Guo Y, Yu X, Liu W, Zhou L. Protective mechanism of rhubarb anthraquinone glycosides in rats with cerebral ischaemia-reperfusion injury: interactions between medicine and intestinal flora. Chin Med 2020;15:60. [PMID: 32518585 DOI: 10.1186/s13020-020-00341-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
231 Rajani C, Jia W. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders. Clin Sci (Lond) 2018;132:791-811. [PMID: 29661926 DOI: 10.1042/CS20171328] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
232 Shavandi A, Saeedi P, Gérard P, Jalalvandi E, Cannella D, Bekhit AE. The role of microbiota in tissue repair and regeneration. J Tissue Eng Regen Med 2020;14:539-55. [PMID: 31845514 DOI: 10.1002/term.3009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
233 Wu R, Yuan X, Li X, Ma N, Jiang H, Tang H, Xu G, Liu Z, Zhang Z. The bile acid-activated retinoic acid response in dendritic cells is involved in food allergen sensitization. Allergy 2021. [PMID: 34365653 DOI: 10.1111/all.15039] [Reference Citation Analysis]
234 Khalyfa A, Ericsson A, Qiao Z, Almendros I, Farré R, Gozal D. Circulating exosomes and gut microbiome induced insulin resistance in mice exposed to intermittent hypoxia: Effects of physical activity. EBioMedicine 2021;64:103208. [PMID: 33485839 DOI: 10.1016/j.ebiom.2021.103208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
235 Lin H, An Y, Tang H, Wang Y. Alterations of Bile Acids and Gut Microbiota in Obesity Induced by High Fat Diet in Rat Model. J Agric Food Chem 2019;67:3624-32. [PMID: 30832480 DOI: 10.1021/acs.jafc.9b00249] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
236 Wu S, Li T, Niu H, Zhu Y, Liu Y, Duan Y, Sun Q, Yang X. Effects of glucose oxidase on growth performance, gut function, and cecal microbiota of broiler chickens. Poult Sci 2019;98:828-41. [PMID: 30169708 DOI: 10.3382/ps/pey393] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
237 Lu J, Xie G, Jia W, Jia W. Metabolomics in human type 2 diabetes research. Front Med. 2013;7:4-13. [PMID: 23377891 DOI: 10.1007/s11684-013-0248-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
238 Zhang Y, Zhao F, Deng Y, Zhao Y, Ren H. Metagenomic and metabolomic analysis of the toxic effects of trichloroacetamide-induced gut microbiome and urine metabolome perturbations in mice. J Proteome Res 2015;14:1752-61. [PMID: 25609144 DOI: 10.1021/pr5011263] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
239 Kastl AJ Jr, Terry NA, Wu GD, Albenberg LG. The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cell Mol Gastroenterol Hepatol 2020;9:33-45. [PMID: 31344510 DOI: 10.1016/j.jcmgh.2019.07.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 28] [Article Influence: 27.5] [Reference Citation Analysis]
240 Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-Modulated Metabolites at the Interface of Host Immunity. J I 2017;198:572-80. [DOI: 10.4049/jimmunol.1601247] [Cited by in Crossref: 134] [Cited by in F6Publishing: 107] [Article Influence: 33.5] [Reference Citation Analysis]
241 Guo JL, Kuang WM, Zhong YF, Zhou YL, Chen YJ, Lin SM. Effects of supplemental dietary bile acids on growth, liver function and immunity of juvenile largemouth bass(Micropterus salmoides)fed high-starch diet. Fish Shellfish Immunol 2020;97:602-7. [PMID: 31899355 DOI: 10.1016/j.fsi.2019.12.087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
242 Hwang I, Park YJ, Kim YR, Kim YN, Ka S, Lee HY, Seong JK, Seok YJ, Kim JB. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J. 2015;29:2397-2411. [PMID: 25713030 DOI: 10.1096/fj.14-265983] [Cited by in Crossref: 117] [Cited by in F6Publishing: 105] [Article Influence: 19.5] [Reference Citation Analysis]
243 Lu K, Abo RP, Schlieper KA, Graffam ME, Levine S, Wishnok JS, Swenberg JA, Tannenbaum SR, Fox JG. Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect 2014;122:284-91. [PMID: 24413286 DOI: 10.1289/ehp.1307429] [Cited by in Crossref: 292] [Cited by in F6Publishing: 233] [Article Influence: 41.7] [Reference Citation Analysis]
244 Chávez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology 2017;152:1679-1694.e3. [PMID: 28214524 DOI: 10.1053/j.gastro.2017.01.055] [Cited by in Crossref: 269] [Cited by in F6Publishing: 229] [Article Influence: 67.3] [Reference Citation Analysis]
245 Saad MJ, Santos A, Prada PO. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology (Bethesda). 2016;31:283-293. [PMID: 27252163 DOI: 10.1152/physiol.00041.2015] [Cited by in Crossref: 169] [Cited by in F6Publishing: 162] [Article Influence: 42.3] [Reference Citation Analysis]
246 Chen J, Thomsen M, Vitetta L. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. J Cell Biochem 2019;120:2713-20. [PMID: 30443932 DOI: 10.1002/jcb.27635] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 12.7] [Reference Citation Analysis]
247 Man AWC, Zhou Y, Xia N, Li H. Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism. Nutrients 2020;12:E3054. [PMID: 33036205 DOI: 10.3390/nu12103054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
248 Zeevi D, Korem T, Godneva A, Bar N, Kurilshikov A, Lotan-Pompan M, Weinberger A, Fu J, Wijmenga C, Zhernakova A, Segal E. Structural variation in the gut microbiome associates with host health. Nature. 2019;568:43-48. [PMID: 30918406 DOI: 10.1038/s41586-019-1065-y] [Cited by in Crossref: 106] [Cited by in F6Publishing: 75] [Article Influence: 53.0] [Reference Citation Analysis]
249 Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res. 2015;56:1085-1099. [PMID: 25210150 DOI: 10.1194/jlr.r054114] [Cited by in Crossref: 216] [Cited by in F6Publishing: 108] [Article Influence: 30.9] [Reference Citation Analysis]
250 Dethloff F, Vargas F, Elijah E, Quinn R, Park DI, Herzog DP, Müller MB, Gentry EC, Knight R, Gonzalez A, Dorrestein PC, Turck CW. Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice. Front Psychiatry 2020;11:518. [PMID: 32581888 DOI: 10.3389/fpsyt.2020.00518] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Wieland A, Frank DN, Harnke B, Bambha K. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2015;42:1051-1063. [PMID: 26304302 DOI: 10.1111/apt.13376] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 17.0] [Reference Citation Analysis]
252 Kirpich IA, Marsano LS, McClain CJ. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem. 2015;48:923-930. [PMID: 26151226 DOI: 10.1016/j.clinbiochem.2015.06.023] [Cited by in Crossref: 128] [Cited by in F6Publishing: 111] [Article Influence: 21.3] [Reference Citation Analysis]
253 Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 2011;19:349-359. [PMID: 21684749 DOI: 10.1016/j.tim.2011.05.006] [Cited by in Crossref: 327] [Cited by in F6Publishing: 250] [Article Influence: 32.7] [Reference Citation Analysis]
254 Marion S, Desharnais L, Studer N, Dong Y, Notter MD, Poudel S, Menin L, Janowczyk A, Hettich RL, Hapfelmeier S, Bernier-Latmani R. Biogeography of microbial bile acid transformations along the murine gut. J Lipid Res 2020;61:1450-63. [PMID: 32661017 DOI: 10.1194/jlr.RA120001021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
255 Bang S, Lee E, Song E, Nam Y, Seo M, Kim H, Park C, Lim MY, Seo D. Effect of raw potato starch on the gut microbiome and metabolome in mice. International Journal of Biological Macromolecules 2019;133:37-43. [DOI: 10.1016/j.ijbiomac.2019.04.085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
256 Mitsinikos FT, Chac D, Schillingford N, DePaolo RW. Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease. Gut Microbes 2020;12:1-16. [PMID: 32816619 DOI: 10.1080/19490976.2020.1792256] [Reference Citation Analysis]
257 Aw W, Fukuda S. The Role of Integrated Omics in Elucidating the Gut Microbiota Health Potentials. In: Liong M, editor. Beneficial Microorganisms in Medical and Health Applications. Cham: Springer International Publishing; 2015. pp. 73-100. [DOI: 10.1007/978-3-319-23213-3_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
258 Zhang J, Xiong F, Wang G, Li W, Li M, Zou H, Wu S. The influence of diet on the grass carp intestinal microbiota and bile acids. Aquac Res 2017;48:4934-44. [DOI: 10.1111/are.13312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
259 Devaraj S, Hemarajata P, Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem. 2013;59:617-628. [PMID: 23401286 DOI: 10.1373/clinchem.2012.187617] [Cited by in Crossref: 172] [Cited by in F6Publishing: 131] [Article Influence: 21.5] [Reference Citation Analysis]
260 Machado MV, Cortez-Pinto H. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci. 2016;17:481. [PMID: 27043550 DOI: 10.3390/ijms17040481] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
261 Selber-Hnatiw S, Sultana T, Tse W, Abdollahi N, Abdullah S, Al Rahbani J, Alazar D, Alrumhein NJ, Aprikian S, Arshad R, Azuelos JD, Bernadotte D, Beswick N, Chazbey H, Church K, Ciubotaru E, D'Amato L, Del Corpo T, Deng J, Di Giulio BL, Diveeva D, Elahie E, Frank JGM, Furze E, Garner R, Gibbs V, Goldberg-Hall R, Goldman CJ, Goltsios FF, Gorjipour K, Grant T, Greco B, Guliyev N, Habrich A, Hyland H, Ibrahim N, Iozzo T, Jawaheer-Fenaoui A, Jaworski JJ, Jhajj MK, Jones J, Joyette R, Kaudeer S, Kelley S, Kiani S, Koayes M, Kpata AJAL, Maingot S, Martin S, Mathers K, McCullogh S, McNamara K, Mendonca J, Mohammad K, Momtaz SA, Navaratnarajah T, Nguyen-Duong K, Omran M, Ortiz A, Patel A, Paul-Cole K, Plaisir PA, Porras Marroquin JA, Prevost A, Quach A, Rafal AJ, Ramsarun R, Rhnima S, Rili L, Safir N, Samson E, Sandiford RR, Secondi S, Shahid S, Shahroozi M, Sidibé F, Smith M, Sreng Flores AM, Suarez Ybarra A, Sénéchal R, Taifour T, Tang L, Trapid A, Tremblay Potvin M, Wainberg J, Wang DN, Weissenberg M, White A, Wilkinson G, Williams B, Wilson JR, Zoppi J, Zouboulakis K, Gamberi C. Metabolic networks of the human gut microbiota.Microbiology (Reading). 2020;166:96-119. [PMID: 31799915 DOI: 10.1099/mic.0.000853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
262 Zhang Y, Limaye PB, Renaud HJ, Klaassen CD. Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice. Toxicol Appl Pharmacol. 2014;277:138-145. [PMID: 24657338 DOI: 10.1016/j.taap.2014.03.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 9.4] [Reference Citation Analysis]
263 Rath CM, Alexandrov T, Higginbottom SK, Song J, Milla ME, Fischbach MA, Sonnenburg JL, Dorrestein PC. Molecular analysis of model gut microbiotas by imaging mass spectrometry and nanodesorption electrospray ionization reveals dietary metabolite transformations. Anal Chem 2012;84:9259-67. [PMID: 23009651 DOI: 10.1021/ac302039u] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
264 Mattner J. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC). Int J Mol Sci. 2016;17. [PMID: 27834858 DOI: 10.3390/ijms17111864] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
265 Kobyliak N, Virchenko O, Falalyeyeva T. Pathophysiological role of host microbiota in the development of obesity. Nutr J. 2016;15:43. [PMID: 27105827 DOI: 10.1186/s12937-016-0166-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
266 Cӑtoi AF, Vodnar DC, Corina A, Nikolic D, Citarrella R, Pérez-Martínez P, Rizzo M. Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives. Curr Pharm Des 2019;25:2038-50. [PMID: 31298152 DOI: 10.2174/1381612825666190708190437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
267 Sun L, Xu H, Ye J, Gaikwad NW. Comparative effect of black, green, oolong, and white tea intake on weight gain and bile acid metabolism. Nutrition 2019;65:208-15. [PMID: 31031064 DOI: 10.1016/j.nut.2019.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
268 Zhang N, Chen W, Yin H, Liu W, He X. Biliary Jejunostomy Might Improve Glucose in Type 2 Diabetes Patients. Obes Surg 2020;30:1446-51. [PMID: 31811623 DOI: 10.1007/s11695-019-04319-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Laferrère B, Pattou F. Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 2018;9:530. [PMID: 30250454 DOI: 10.3389/fendo.2018.00530] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
270 Chi L, Lai Y, Tu P, Liu CW, Xue J, Ru H, Lu K. Lipid and Cholesterol Homeostasis after Arsenic Exposure and Antibiotic Treatment in Mice: Potential Role of the Microbiota. Environ Health Perspect 2019;127:97002. [PMID: 31532247 DOI: 10.1289/EHP4415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 7.5] [Reference Citation Analysis]
271 Bashiardes S, Shapiro H, Rozin S, Shibolet O, Elinav E. Non-alcoholic fatty liver and the gut microbiota. Mol Metab. 2016;5:782-794. [PMID: 27617201 DOI: 10.1016/j.molmet.2016.06.003] [Cited by in Crossref: 121] [Cited by in F6Publishing: 94] [Article Influence: 24.2] [Reference Citation Analysis]
272 Muirhead LJ, Kinross J, FitzMaurice TS, Takats Z, Darzi A, Nicholson JK. Surgical systems biology and personalized longitudinal phenotyping in critical care. Per Med 2012;9:593-608. [PMID: 29768802 DOI: 10.2217/pme.12.70] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
273 Ridlon JM, Bajaj JS. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharm Sin B 2015;5:99-105. [PMID: 26579434 DOI: 10.1016/j.apsb.2015.01.006] [Cited by in Crossref: 95] [Cited by in F6Publishing: 75] [Article Influence: 15.8] [Reference Citation Analysis]
274 Long SL, Gahan CGM, Joyce SA. Interactions between gut bacteria and bile in health and disease. Mol Aspects Med. 2017;56:54-65. [PMID: 28602676 DOI: 10.1016/j.mam.2017.06.002] [Cited by in Crossref: 160] [Cited by in F6Publishing: 134] [Article Influence: 40.0] [Reference Citation Analysis]
275 Shapiro H, Thaiss CA, Levy M, Elinav E. The cross talk between microbiota and the immune system: metabolites take center stage. Curr Opin Immunol 2014;30:54-62. [PMID: 25064714 DOI: 10.1016/j.coi.2014.07.003] [Cited by in Crossref: 103] [Cited by in F6Publishing: 85] [Article Influence: 14.7] [Reference Citation Analysis]
276 Ryan PM, Stanton C, Caplice NM. Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions. Diabetol Metab Syndr 2017;9:102. [PMID: 29299069 DOI: 10.1186/s13098-017-0299-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
277 Hosseinkhani F, Heinken A, Thiele I, Lindenburg PW, Harms AC, Hankemeier T. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes 2021;13:1-22. [PMID: 33590776 DOI: 10.1080/19490976.2021.1882927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
278 Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice. Cell Reports 2014;7:12-8. [DOI: 10.1016/j.celrep.2014.02.032] [Cited by in Crossref: 181] [Cited by in F6Publishing: 162] [Article Influence: 25.9] [Reference Citation Analysis]
279 Zwicker BL, Agellon LB. Transport and biological activities of bile acids. Int J Biochem Cell Biol 2013;45:1389-98. [PMID: 23603607 DOI: 10.1016/j.biocel.2013.04.012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
280 Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2020;11:158-171. [PMID: 31595814 DOI: 10.1080/19490976.2019.1674124] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 22.5] [Reference Citation Analysis]
281 Abdou RM, Zhu L, Baker RD, Baker SS. Gut Microbiota of Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2016;61:1268-1281. [PMID: 26898658 DOI: 10.1007/s10620-016-4045-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 7.4] [Reference Citation Analysis]
282 Zhang CX, Wang HY, Chen TX. Interactions between Intestinal Microflora/Probiotics and the Immune System. Biomed Res Int 2019;2019:6764919. [PMID: 31828119 DOI: 10.1155/2019/6764919] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
283 Spinelli V, Lalloyer F, Baud G, Osto E, Kouach M, Daoudi M, Vallez E, Raverdy V, Goossens JF, Descat A. Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. Int J Obes (Lond). 2016;40:1260-1267. [PMID: 27089995 DOI: 10.1038/ijo.2016.46] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
284 Holmes E, Kinross J, Gibson GR, Burcelin R, Jia W, Pettersson S, Nicholson JK. Therapeutic Modulation of Microbiota-Host Metabolic Interactions. Science Translational Medicine 2012;4:137rv6-137rv6. [DOI: 10.1126/scitranslmed.3004244] [Cited by in Crossref: 159] [Cited by in F6Publishing: 133] [Article Influence: 17.7] [Reference Citation Analysis]
285 Behr C, Kamp H, Fabian E, Krennrich G, Mellert W, Peter E, Strauss V, Walk T, Rietjens IMCM, van Ravenzwaay B. Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats. Arch Toxicol 2017;91:3439-54. [PMID: 28337503 DOI: 10.1007/s00204-017-1949-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
286 Yan J, Xie G, Liang C, Hu Y, Zhao A, Huang F, Hu P, Liu P, Jia W, Wang X. Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats. Sci Rep 2017;7:4211. [PMID: 28646179 DOI: 10.1038/s41598-017-04536-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
287 Li T, Chiang JYL. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. Hepatobiliary Surg Nutr 2020;9:152-69. [PMID: 32355674 DOI: 10.21037/hbsn.2019.09.03] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
288 Xie G, Wang X, Jiang R, Zhao A, Yan J, Zheng X, Huang F, Liu X, Panee J, Rajani C, Yao C, Yu H, Jia W, Sun B, Liu P. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure. EBioMedicine. 2018;37:294-306. [PMID: 30344125 DOI: 10.1016/j.ebiom.2018.10.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
289 Pierre JF, Martinez KB, Ye H, Nadimpalli A, Morton TC, Yang J, Wang Q, Patno N, Chang EB, Yin DP. Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice. Am J Physiol Gastrointest Liver Physiol 2016;311:G286-304. [PMID: 27340128 DOI: 10.1152/ajpgi.00202.2016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
290 Bindels LB, Delzenne NM. Muscle wasting: the gut microbiota as a new therapeutic target? Int J Biochem Cell Biol 2013;45:2186-90. [PMID: 23831839 DOI: 10.1016/j.biocel.2013.06.021] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 10.5] [Reference Citation Analysis]
291 Biagioli M, Carino A. Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity. In: Fiorucci S, Distrutti E, editors. Bile Acids and Their Receptors. Cham: Springer International Publishing; 2019. pp. 95-108. [DOI: 10.1007/164_2019_225] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
292 Martin FP, Collino S, Rezzi S. 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health. Magn Reson Chem 2011;49 Suppl 1:S47-54. [PMID: 22290709 DOI: 10.1002/mrc.2810] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
293 Wu J, Wang K, Wang X, Pang Y, Jiang C. The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell 2021;12:360-73. [PMID: 33346905 DOI: 10.1007/s13238-020-00814-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
294 Sun J, Cao Z, Smith AD, Carlson PE Jr, Coryell M, Chen H, Beger RD. Bile Acid Profile and its Changes in Response to Cefoperazone Treatment in MR1 Deficient Mice. Metabolites 2020;10:E127. [PMID: 32225042 DOI: 10.3390/metabo10040127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
295 Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 2016;7:22-39. [PMID: 26939849 DOI: 10.1080/19490976.2015.1127483] [Cited by in Crossref: 301] [Cited by in F6Publishing: 248] [Article Influence: 60.2] [Reference Citation Analysis]
296 Mahalak KK, Firrman J, Tomasula PM, Nuñez A, Lee JJ, Bittinger K, Rinaldi W, Liu LS. Impact of Steviol Glycosides and Erythritol on the Human and Cebus apella Gut Microbiome. J Agric Food Chem 2020;68:13093-101. [PMID: 31869223 DOI: 10.1021/acs.jafc.9b06181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
297 Hegade VS, Pechlivanis A, Mcdonald JAK, Rees D, Corrigan M, Hirschfield GM, Taylor‐robinson SD, Holmes E, Marchesi JR, Kendrick S, Jones DE. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus. Liver Int 2019;39:967-75. [DOI: 10.1111/liv.14069] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
298 Moco S, Martin FP, Rezzi S. Metabolomics view on gut microbiome modulation by polyphenol-rich foods. J Proteome Res 2012;11:4781-90. [PMID: 22905879 DOI: 10.1021/pr300581s] [Cited by in Crossref: 145] [Cited by in F6Publishing: 109] [Article Influence: 16.1] [Reference Citation Analysis]
299 Blekhman R, Goodrich JK, Huang K, Sun Q, Bukowski R, Bell JT, Spector TD, Keinan A, Ley RE, Gevers D, Clark AG. Host genetic variation impacts microbiome composition across human body sites. Genome Biol 2015;16:191. [PMID: 26374288 DOI: 10.1186/s13059-015-0759-1] [Cited by in Crossref: 394] [Cited by in F6Publishing: 300] [Article Influence: 65.7] [Reference Citation Analysis]
300 Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Front Med (Lausanne) 2020;7:448. [PMID: 32974366 DOI: 10.3389/fmed.2020.00448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
301 Qi Y, Jiang C, Cheng J, Krausz KW, Li T, Ferrell JM, Gonzalez FJ, Chiang JY. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice. Biochim Biophys Acta. 2015;1851:19-29. [PMID: 24796972 DOI: 10.1016/j.bbalip.2014.04.008] [Cited by in Crossref: 101] [Cited by in F6Publishing: 81] [Article Influence: 14.4] [Reference Citation Analysis]
302 Nie YF, Hu J, Yan XH. Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J Zhejiang Univ Sci B. 2015;16:436-446. [PMID: 26055905 DOI: 10.1631/jzus.b1400327] [Cited by in Crossref: 62] [Cited by in F6Publishing: 33] [Article Influence: 12.4] [Reference Citation Analysis]
303 Aw W, Fukuda S. Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol 2015;37:5-16. [PMID: 25338280 DOI: 10.1007/s00281-014-0456-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
304 Ojeda P, Bobe A, Dolan K, Leone V, Martinez K. Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology. J Nutr Biochem 2016;28:191-200. [PMID: 26372091 DOI: 10.1016/j.jnutbio.2015.08.013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
305 Sun X, Winglee K, Gharaibeh RZ, Gauthier J, He Z, Tripathi P, Avram D, Bruner S, Fodor A, Jobin C. Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice. Gastroenterology 2018;154:1751-1763.e2. [PMID: 29408609 DOI: 10.1053/j.gastro.2018.01.042] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 12.3] [Reference Citation Analysis]
306 Srinivasan K, Buys EM. Insights into the role of bacteria in vitamin A biosynthesis: Future research opportunities. Crit Rev Food Sci Nutr 2019;59:3211-26. [PMID: 30638045 DOI: 10.1080/10408398.2018.1546670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
307 Nichols RG, Hume NE, Smith PB, Peters JM, Patterson AD. Omics Approaches To Probe Microbiota and Drug Metabolism Interactions. Chem Res Toxicol 2016;29:1987-97. [PMID: 27782392 DOI: 10.1021/acs.chemrestox.6b00236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
308 Yu Z, Shi Z, Zheng Z, Han J, Yang W, Lu R, Lin W, Zheng Y, Nie D, Chen G. DEHP induce cholesterol imbalance via disturbing bile acid metabolism by altering the composition of gut microbiota in rats. Chemosphere 2021;263:127959. [PMID: 32814133 DOI: 10.1016/j.chemosphere.2020.127959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
309 Mao L, Fang S, Zhao M, Liu W, Jin H. Effects of Bisphenol A and Bisphenol S Exposure at Low Doses on the Metabolome of Adolescent Male Sprague-Dawley Rats. Chem Res Toxicol 2021;34:1578-87. [PMID: 34019419 DOI: 10.1021/acs.chemrestox.1c00018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Barra NG, Palanivel R, Denou E, Chew MV, Gillgrass A, Walker TD, Kong J, Richards CD, Jordana M, Collins SM, Trigatti BL, Holloway AC, Raha S, Steinberg GR, Ashkar AA. Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity. PLoS One 2014;9:e114799. [PMID: 25517731 DOI: 10.1371/journal.pone.0114799] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
311 Theriot CM, Young VB. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes 2014;5:86-95. [PMID: 24335555 DOI: 10.4161/gmic.27131] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
312 Mancini A, Campagna F, Amodio P, Tuohy KM. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food Funct. 2018;9:1373-1388. [PMID: 29485654 DOI: 10.1039/c7fo01528c] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
313 Bäckhed F. Programming of host metabolism by the gut microbiota. Ann Nutr Metab. 2011;58 Suppl 2:44-52. [PMID: 21846980 DOI: 10.1159/000328042] [Cited by in Crossref: 138] [Cited by in F6Publishing: 116] [Article Influence: 13.8] [Reference Citation Analysis]
314 Park JS, Seo JH, Youn HS. Gut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease. Pediatr Gastroenterol Hepatol Nutr. 2013;16:22-27. [PMID: 24010102 DOI: 10.5223/pghn.2013.16.1.22] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
315 Carvalho BM, Saad MJ. Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm. 2013;2013:986734. [PMID: 23840101 DOI: 10.1155/2013/986734] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
316 Hartstra AV, Schüppel V, Imangaliyev S, Schrantee A, Prodan A, Collard D, Levin E, Dallinga-Thie G, Ackermans MT, Winkelmeijer M, Havik SR, Metwaly A, Lagkouvardos I, Nier A, Bergheim I, Heikenwalder M, Dunkel A, Nederveen AJ, Liebisch G, Mancano G, Claus SP, Benítez-Páez A, la Fleur SE, Bergman JJ, Gerdes V, Sanz Y, Booij J, Kemper E, Groen AK, Serlie MJ, Haller D, Nieuwdorp M. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome. Mol Metab 2020;42:101076. [PMID: 32916306 DOI: 10.1016/j.molmet.2020.101076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
317 Hanhineva K, Barri T, Kolehmainen M, Pekkinen J, Pihlajamäki J, Vesterbacka A, Solano-aguilar G, Mykkänen H, Dragsted LO, Urban JF, Poutanen K. Comparative Nontargeted Profiling of Metabolic Changes in Tissues and Biofluids in High-Fat Diet-Fed Ossabaw Pig. J Proteome Res 2013;12:3980-92. [DOI: 10.1021/pr400257d] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
318 Higashimura Y, Naito Y, Takagi T, Uchiyama K, Mizushima K, Ushiroda C, Ohnogi H, Kudo Y, Yasui M, Inui S, Hisada T, Honda A, Matsuzaki Y, Yoshikawa T. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice. Am J Physiol Gastrointest Liver Physiol 2016;310:G367-75. [PMID: 26767984 DOI: 10.1152/ajpgi.00324.2015] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 10.4] [Reference Citation Analysis]
319 Ridlon JM, Ikegawa S, Alves JM, Zhou B, Kobayashi A, Iida T, Mitamura K, Tanabe G, Serrano M, De Guzman A, Cooper P, Buck GA, Hylemon PB. Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens. J Lipid Res 2013;54:2437-49. [PMID: 23772041 DOI: 10.1194/jlr.M038869] [Cited by in Crossref: 104] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
320 Baars A, Oosting A, Lohuis M, Koehorst M, El Aidy S, Hugenholtz F, Smidt H, Mischke M, Boekschoten MV, Verkade HJ, Garssen J, van der Beek EM, Knol J, de Vos P, van Bergenhenegouwen J, Fransen F. Sex differences in lipid metabolism are affected by presence of the gut microbiota. Sci Rep 2018;8:13426. [PMID: 30194317 DOI: 10.1038/s41598-018-31695-w] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
321 Albaugh VL, Banan B, Ajouz H, Abumrad NN, Flynn CR. Bile acids and bariatric surgery. Mol Aspects Med 2017;56:75-89. [PMID: 28390813 DOI: 10.1016/j.mam.2017.04.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 14.0] [Reference Citation Analysis]
322 Pereira-Fantini PM, Lapthorne S, Joyce SA, Dellios NL, Wilson G, Fouhy F, Thomas SL, Scurr M, Hill C, Gahan CG. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease. J Hepatol. 2014;61:1115-1125. [PMID: 24999016 DOI: 10.1016/j.jhep.2014.06.025] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
323 Eggink HM, Oosterman JE, de Goede P, de Vries EM, Foppen E, Koehorst M, Groen AK, Boelen A, Romijn JA, la Fleur SE, Soeters MR, Kalsbeek A. Complex interaction between circadian rhythm and diet on bile acid homeostasis in male rats. Chronobiol Int 2017;34:1339-53. [PMID: 29028359 DOI: 10.1080/07420528.2017.1363226] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
324 Lahti L, Salonen A, Kekkonen RA, Salojärvi J, Jalanka-Tuovinen J, Palva A, Orešič M, de Vos WM. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. PeerJ 2013;1:e32. [PMID: 23638368 DOI: 10.7717/peerj.32] [Cited by in Crossref: 124] [Cited by in F6Publishing: 105] [Article Influence: 15.5] [Reference Citation Analysis]
325 Macpherson AJ, McCoy KD. Standardised animal models of host microbial mutualism. Mucosal Immunol 2015;8:476-86. [PMID: 25492472 DOI: 10.1038/mi.2014.113] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 11.9] [Reference Citation Analysis]
326 Kok MG, Ruijken MM, Swann JR, Wilson ID, Somsen GW, de Jong GJ. Anionic metabolic profiling of urine from antibiotic-treated rats by capillary electrophoresis-mass spectrometry. Anal Bioanal Chem 2013;405:2585-94. [PMID: 23314487 DOI: 10.1007/s00216-012-6701-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
327 McCall LI, Tripathi A, Vargas F, Knight R, Dorrestein PC, Siqueira-Neto JL. Experimental Chagas disease-induced perturbations of the fecal microbiome and metabolome. PLoS Negl Trop Dis 2018;12:e0006344. [PMID: 29529084 DOI: 10.1371/journal.pntd.0006344] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
328 Tulipani S, Griffin J, Palau-rodriguez M, Mora-cubillos X, Bernal-lopez RM, Tinahones FJ, Corkey BE, Andres-lacueva C. Metabolomics-guided insights on bariatric surgery versus behavioral interventions for weight loss: Metabolomics of Bariatric Versus Dietary Weight Loss. Obesity 2016;24:2451-66. [DOI: 10.1002/oby.21686] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
329 Chu L, Zhang K, Zhang Y, Jin X, Jiang H. Mechanism underlying an elevated serum bile acid level in chronic renal failure patients. Int Urol Nephrol 2015;47:345-51. [PMID: 25539619 DOI: 10.1007/s11255-014-0901-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
330 Kinross J, Li JV, Muirhead LJ, Nicholson J. Nutritional modulation of the metabonome: applications of metabolic phenotyping in translational nutritional research. Curr Opin Gastroenterol 2014;30:196-207. [PMID: 24468802 DOI: 10.1097/MOG.0000000000000036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
331 Elsherbiny NM, Rammadan M, Hassan EA, Ali ME, El-Rehim ASA, Abbas WA, Abozaid MAA, Hassanin E, Hetta HF. Autoimmune Hepatitis: Shifts in Gut Microbiota and Metabolic Pathways among Egyptian Patients. Microorganisms 2020;8:E1011. [PMID: 32640728 DOI: 10.3390/microorganisms8071011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
332 Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362:776-780. [PMID: 30442802 DOI: 10.1126/science.aau5812] [Cited by in Crossref: 294] [Cited by in F6Publishing: 226] [Article Influence: 147.0] [Reference Citation Analysis]
333 Kolodziejczyk AA, Zheng D, Elinav E. Diet–microbiota interactions and personalized nutrition. Nat Rev Microbiol 2019;17:742-53. [DOI: 10.1038/s41579-019-0256-8] [Cited by in Crossref: 186] [Cited by in F6Publishing: 131] [Article Influence: 93.0] [Reference Citation Analysis]
334 Janssen AWF, Houben T, Katiraei S, Dijk W, Boutens L, van der Bolt N, Wang Z, Brown JM, Hazen SL, Mandard S, Shiri-Sverdlov R, Kuipers F, Willems van Dijk K, Vervoort J, Stienstra R, Hooiveld GJEJ, Kersten S. Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. J Lipid Res. 2017;58:1399-1416. [PMID: 28533304 DOI: 10.1194/jlr.m075713] [Cited by in Crossref: 56] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
335 Breen DM, Rasmussen BA, Côté CD, Jackson VM, Lam TK. Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes 2013;62:3005-13. [PMID: 23970519 DOI: 10.2337/db13-0523] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
336 Liu L, Liu Z, Li H, Cao Z, Li W, Song Z, Li X, Lu A, Lu C, Liu Y. Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver-Gut Axis. Front Pharmacol 2020;11:12. [PMID: 32116693 DOI: 10.3389/fphar.2020.00012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
337 Swann JR, Tuohy KM, Lindfors P, Brown DT, Gibson GR, Wilson ID, Sidaway J, Nicholson JK, Holmes E. Variation in antibiotic-induced microbial recolonization impacts on the host metabolic phenotypes of rats. J Proteome Res. 2011;10:3590-3603. [PMID: 21591676 DOI: 10.1021/pr200243t] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 9.7] [Reference Citation Analysis]
338 Ridlon JM, Devendran S, Alves JM, Doden H, Wolf PG, Pereira GV, Ly L, Volland A, Takei H, Nittono H, Murai T, Kurosawa T, Chlipala GE, Green SJ, Hernandez AG, Fields CJ, Wright CL, Kakiyama G, Cann I, Kashyap P, McCracken V, Gaskins HR. The 'in vivo lifestyle' of bile acid 7α-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice. Gut Microbes 2020;11:381-404. [PMID: 31177942 DOI: 10.1080/19490976.2019.1618173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
339 Fröhlich EE, Farzi A, Mayerhofer R, Reichmann F, Jačan A, Wagner B, Zinser E, Bordag N, Magnes C, Fröhlich E, Kashofer K, Gorkiewicz G, Holzer P. Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain Behav Immun 2016;56:140-55. [PMID: 26923630 DOI: 10.1016/j.bbi.2016.02.020] [Cited by in Crossref: 278] [Cited by in F6Publishing: 227] [Article Influence: 55.6] [Reference Citation Analysis]
340 Geier FM, Want EJ, Leroi AM, Bundy JG. Cross-Platform Comparison of Caenorhabditis elegans Tissue Extraction Strategies for Comprehensive Metabolome Coverage. Anal Chem 2011;83:3730-6. [DOI: 10.1021/ac2001109] [Cited by in Crossref: 89] [Cited by in F6Publishing: 72] [Article Influence: 8.9] [Reference Citation Analysis]
341 Sanmiguel C, Gupta A, Mayer EA. Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep. 2015;4:250-261. [PMID: 26029487 DOI: 10.1007/s13679-015-0152-0] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 15.8] [Reference Citation Analysis]
342 Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol. 2014;20:16452-16463. [PMID: 25469013 DOI: 10.3748/wjg.v20.i44.16452] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 68] [Article Influence: 14.8] [Reference Citation Analysis]
343 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
344 Martinez KB, Pierre JF, Chang EB. The Gut Microbiota: The Gateway to Improved Metabolism. Gastroenterol Clin North Am 2016;45:601-14. [PMID: 27837775 DOI: 10.1016/j.gtc.2016.07.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
345 Winer DA, Luck H, Tsai S, Winer S. The Intestinal Immune System in Obesity and Insulin Resistance. Cell Metab. 2016;23:413-426. [PMID: 26853748 DOI: 10.1016/j.cmet.2016.01.003] [Cited by in Crossref: 202] [Cited by in F6Publishing: 163] [Article Influence: 40.4] [Reference Citation Analysis]
346 Hay A, Zhu J. In Sickness and in Health. Elsevier; 2016. pp. 43-64. [DOI: 10.1016/bs.aambs.2016.07.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
347 Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol. 2015;21:11597-11608. [PMID: 26556989 DOI: 10.3748/wjg.v21.i41.11597] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
348 Ma X, Chi C, Fan L, Dong B, Shao X, Xie S, Li M, Xue W. The Microbiome of Prostate Fluid Is Associated With Prostate Cancer. Front Microbiol 2019;10:1664. [PMID: 31379800 DOI: 10.3389/fmicb.2019.01664] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
349 Chakraborty S, Mandal J, Yang T, Cheng X, Yeo JY, McCarthy CG, Wenceslau CF, Koch LG, Hill JW, Vijay-Kumar M, Joe B. Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award. Hypertension 2020;75:1386-96. [PMID: 32336227 DOI: 10.1161/HYPERTENSIONAHA.120.13896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
350 Hunt JE, Billeschou A, Windeløv JA, Hartmann B, Ullmer C, Holst JJ, Kissow H. Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice. Am J Physiol Gastrointest Liver Physiol 2020;318:G980-7. [PMID: 32308039 DOI: 10.1152/ajpgi.00062.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
351 Dumas M, Kinross J, Nicholson JK. Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver Disease. Gastroenterology 2014;146:46-62. [DOI: 10.1053/j.gastro.2013.11.001] [Cited by in Crossref: 115] [Cited by in F6Publishing: 88] [Article Influence: 16.4] [Reference Citation Analysis]
352 Mullish BH, McDonald JAK, Pechlivanis A, Allegretti JR, Kao D, Barker GF, Kapila D, Petrof EO, Joyce SA, Gahan CGM, Glegola-Madejska I, Williams HRT, Holmes E, Clarke TB, Thursz MR, Marchesi JR. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection. Gut. 2019;68:1791-1800. [PMID: 30816855 DOI: 10.1136/gutjnl-2018-317842] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 37.5] [Reference Citation Analysis]
353 Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513-1524. [PMID: 24440671 DOI: 10.1053/j.gastro.2014.01.020] [Cited by in Crossref: 487] [Cited by in F6Publishing: 426] [Article Influence: 69.6] [Reference Citation Analysis]
354 van der Lelie D, Oka A, Taghavi S, Umeno J, Fan TJ, Merrell KE, Watson SD, Ouellette L, Liu B, Awoniyi M, Lai Y, Chi L, Lu K, Henry CS, Sartor RB. Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis. Nat Commun 2021;12:3105. [PMID: 34050144 DOI: 10.1038/s41467-021-23460-x] [Reference Citation Analysis]
355 Janssen AW, Kersten S. Potential mediators linking gut bacteria to metabolic health: a critical view. J Physiol. 2017;595:477-487. [PMID: 27418465 DOI: 10.1113/jp272476] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 6.6] [Reference Citation Analysis]
356 Garruti G, Di Ciaula A, Wang HH, Wang DQ, Portincasa P. Cross-Talk Between Bile Acids and Gastro-Intestinal and Thermogenic Hormones: Clues from Bariatric Surgery. Annals of Hepatology 2017;16:S68-82. [DOI: 10.5604/01.3001.0010.5499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
357 Wang Q, Wang B, Saxena V, Miles L, Tiao J, Mortensen JE, Nathan JD. The gut-liver axis: impact of a mouse model of small-bowel bacterial overgrowth. J Surg Res 2018;221:246-56. [PMID: 29229136 DOI: 10.1016/j.jss.2017.08.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
358 Younge N, Yang Q, Seed PC. Enteral High Fat-Polyunsaturated Fatty Acid Blend Alters the Pathogen Composition of the Intestinal Microbiome in Premature Infants with an Enterostomy. J Pediatr 2017;181:93-101.e6. [PMID: 27856001 DOI: 10.1016/j.jpeds.2016.10.053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
359 Gérard C, Vidal H. Impact of Gut Microbiota on Host Glycemic Control. Front Endocrinol (Lausanne) 2019;10:29. [PMID: 30761090 DOI: 10.3389/fendo.2019.00029] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 22.5] [Reference Citation Analysis]
360 Guo X, Liu S, Wang Z, Zhang X, Li M, Wu B. Metagenomic profiles and antibiotic resistance genes in gut microbiota of mice exposed to arsenic and iron. Chemosphere 2014;112:1-8. [DOI: 10.1016/j.chemosphere.2014.03.068] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
361 Liu HX, Hu Y, Wan YJ. Microbiota and bile acid profiles in retinoic acid-primed mice that exhibit accelerated liver regeneration. Oncotarget 2016;7:1096-106. [PMID: 26701854 DOI: 10.18632/oncotarget.6665] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
362 Forkosh E, Ilan Y. The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy. Open Heart 2019;6:e000993. [PMID: 31168383 DOI: 10.1136/openhrt-2018-000993] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
363 Martin G, Kolida S, Marchesi JR, Want E, Sidaway JE, Swann JR. In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota. Front Microbiol 2018;9:1153. [PMID: 29922256 DOI: 10.3389/fmicb.2018.01153] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
364 Zhou W, Sonnenberg GF. Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut. Trends Immunol 2020;41:721-33. [PMID: 32646594 DOI: 10.1016/j.it.2020.06.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
365 Marion S, Studer N, Desharnais L, Menin L, Escrig S, Meibom A, Hapfelmeier S, Bernier-Latmani R. In vitro and in vivo characterization of Clostridium scindens bile acid transformations. Gut Microbes 2019;10:481-503. [PMID: 30589376 DOI: 10.1080/19490976.2018.1549420] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
366 Quesada-Vázquez S, Aragonès G, Del Bas JM, Escoté X. Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. Cells 2020;9:E176. [PMID: 31936799 DOI: 10.3390/cells9010176] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 19.0] [Reference Citation Analysis]
367 Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016;22:1079-89. [DOI: 10.1038/nm.4185] [Cited by in Crossref: 504] [Cited by in F6Publishing: 429] [Article Influence: 100.8] [Reference Citation Analysis]
368 Dahiya DK, Renuka , Puniya M, Shandilya UK, Dhewa T, Kumar N, Kumar S, Puniya AK, Shukla P. Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review. Front Microbiol. 2017;8:563. [PMID: 28421057 DOI: 10.3389/fmicb.2017.00563] [Cited by in Crossref: 155] [Cited by in F6Publishing: 117] [Article Influence: 38.8] [Reference Citation Analysis]
369 Martí JM, Martínez-Martínez D, Rubio T, Gracia C, Peña M, Latorre A, Moya A, P Garay C. Health and Disease Imprinted in the Time Variability of the Human Microbiome. mSystems 2017;2:e00144-16. [PMID: 28345059 DOI: 10.1128/mSystems.00144-16] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
370 Rao MC. Physiology of Electrolyte Transport in the Gut: Implications for Disease. Compr Physiol 2019;9:947-1023. [PMID: 31187895 DOI: 10.1002/cphy.c180011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
371 Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851-861. [PMID: 30952999 DOI: 10.1038/s41385-019-0162-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 27.0] [Reference Citation Analysis]